Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027544	ex-tbvrvi	— (—)	3619	13898	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Respiratory insufficiency

196

40.39

321.17

4.2

2.8

—

ILD, hospital admissions

440

572

8.19

319.78

3.5

3.6

—

Other interstitial pulmonary diseases

445

587

8.06

319.34

3.5

3.6

—

Interstitial lung disease

445

593

7.98

316.55

3.5

3.6

—

Interstitial lung disease endpoints

445

593

7.98

316.55

3.5

3.6

—

Other respiratory diseases principally affecting the interstitium

481

702

7.23

314.82

3.5

3.6

—

Other chronic obstructive pulmonary disease, including avohilmo

879

1740

4.28

310.32

4.0

3.5

—

COPD, hospital admission 2, with asthma infections

685

1078

5.65

307.65

4.0

3.4

—

Chronic lower respiratory diseases

1580

1608

5.32

307.65

4.3

3.4

—

ILD, hospital admission 2, with pulmonary infections

354

190

20.24

307.65

3.5

3.2

—

Non-allergic asthma (mode), excluding more controls

352

112

32.21

307.65

4.8

2.7

—

Asthma (only as main-diagnosis), excluding more controls

1033

250

24.14

307.65

4.3

2.8

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

637

925

6.13

307.65

4.1

3.5

—

732

1117

6.67

307.65

4.6

3.5

—

COPD/asthma/ILD related infections

1099

1000

5.58

307.65

4.0

3.5

—

Influenza and pneumonia

1681

1366

8.00

307.65

4.1

3.7

—

Asthma-related pneumonia

915

1107

8.61

307.65

4.6

3.3

—

COPD (mode)

574

186

25.10

307.65

3.9

2.7

—

COPD differential diagnosis

740

286

13.12

307.65

3.9

2.8

—

1581

1000

9.81

307.65

4.3

3.5

—

COPD

840

1032

6.87

307.65

4.0

3.0

—

All pneumoniae

1708

1405

8.32

307.65

4.1

3.7

—

Later onset COPD, excluding more controls

370

125

23.71

307.65

3.7

2.8

—

Asthma, unspecified (mode), excluding more controls

746

237

24.08

307.65

4.0

2.7

—

Bacterial pneumoniae

854

780

9.99

307.65

4.4

3.4

—

COPD/asthma related infections

1099

1000

5.58

307.65

4.0

3.5

—

Asthma (diagnoses ohter than nonallergic)

1265

2255

4.74

307.65

4.2

3.6

—

ILD medications

1304

1631

4.39

307.65

4.0

3.7

—

Inflammatory bowel disease treatment related agents

1372

1842

4.22

307.65

4.0

3.7

—

Early onset COPD, excluding more controls

399

139

29.82

307.65

4.3

2.6

—

Asthma, including avohilmo

1392

2107

3.76

307.65

4.1

3.6

—

Asthma and opportunity respiratory infection

353

129

34.05

307.65

6.7

3.6

—

ILD medications: prednisolone, methylprednisolone, prednisone

1346

1619

4.72

307.65

4.1

3.6

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

395

162

18.48

307.65

3.5

3.2

—

Pneumonia, organism unspecified

1663

1321

9.06

307.65

4.1

3.6

—

Bacterial pneumonia, not elsewhere classified

828

727

10.40

307.65

4.5

3.4

—

Other chronic obstructive pulmonary disease

789

1012

6.63

307.65

4.0

3.0

—

Asthma, unspecified (mode)

777

269

22.25

307.65

4.0

2.7

—

First line medication for Crohn's disease

1181

1585

4.07

307.65

4.0

3.7

—

Lung cancer and mesothelioma

381

116

29.26

307.65

3.1

2.7

—

Asthma, hospital admissions 3, pneumonia

916

1108

8.62

307.65

4.6

3.3

—

Asthma, excluding more controls

1069

250

22.76

307.65

4.3

2.8

—

Asthma-related infections

1091

1658

6.62

307.65

4.4

3.5

—

Bacterial pneumonia (organism specified)

923

1229

7.04

307.65

4.3

3.2

—

Non-allergic asthma (mode)

352

118

30.57

307.65

4.8

2.6

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1581

1000

9.81

307.65

4.3

3.5

—

Haemorrhage from respiratory passages

657

857

7.12

307.65

4.2

3.3

—

Asthma, hospital admissions , main diagnosis only

1143

2303

4.46

307.65

4.3

3.6

—

ILD, hospital admissions 3, with pneumonia sepsis

317

179

19.34

307.65

3.5

3.1

—

Pneumonias (Asthma/COPD co-morbidities)

1739

1376

8.69

307.65

4.2

3.5

—

Other pulmonary diagnosis

736

283

13.19

307.65

3.9

2.7

—

Abnormal findings on diagnostic imaging of lung

1139

1599

7.11

307.65

4.3

3.3

—

Cough

667

934

6.93

307.65

4.4

3.7

—

Asthma

1119

283

21.16

307.65

4.3

2.7

—

Asthma (only as main-diagnosis)

1071

283

22.39

307.65

4.3

2.7

—

Oral corticosteroids

1427

1821

4.73

307.65

4.0

3.6

—

Asthma-related pneumonia or sepsis

916

1108

8.62

307.65

4.6

3.3

—

Asthma (mode)

957

286

18.24

307.65

4.0

2.8

—

ILD differential diagnosis

740

286

13.12

307.65

3.9

2.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1697

1429

8.30

307.65

4.1

3.6

—

Asthma, hospital admission 2, infections

1091

1658

6.62

307.65

4.4

3.5

—

Excluding asthma or asthma-COPD overlap

748

283

13.41

307.65

3.9

2.7

—

Asthma/COPD (KELA code 203)

1290

1605

5.61

307.65

4.4

3.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1252

1937

5.96

307.65

4.2

3.4

—

Bronchiectasis

505

164

36.40

307.65

6.2

2.6

—

Other diseases of pleura

790

1580

4.50

302.78

4.0

3.4

—

COPD, hospital admissions

793

1533

4.50

299.51

3.9

3.5

—

ILD, hospital admissions 1, main diag only

404

516

8.36

298.26

3.4

3.6

—

COPD, early/later onset

794

1541

4.46

296.94

4.0

3.5

—

Undetermined asthma, excluding more controls

196

28.83

292.47

4.6

2.7

—

Other acute lower respiratory infections

776

1774

4.25

285.58

4.6

3.6

—

Undetermined asthma

196

26.21

282.93

4.6

2.6

—

Other bacterial diseases

1103

2161

3.48

276.20

4.4

3.5

—

Acute bronchitis

643

1360

4.74

273.49

4.5

3.4

—

Dyspnoea

1074

2337

3.44

273.17

3.8

3.7

—

Bacterial infection, other or unspecified

813

1718

4.08

273.03

3.5

3.4

—

Diseases of the respiratory system

519

318

8.26

271.48

4.0

3.8

—

Abnormalities of breathing

887

1254

4.15

267.86

3.8

3.7

—

Other bacterial diseases

1102

2093

3.38

259.94

4.4

3.5

—

Bacterial infection, other or unspecified

764

1662

4.07

257.75

3.4

—

Allergic asthma (mode), excluding more controls

206

112

18.25

253.65

4.1

2.8

—

COPD, hospital admissions 1, only main diagnosis

640

1213

4.65

252.98

3.9

3.5

—

1150

1786

3.36

249.90

4.2

3.4

—

Allergic asthma (mode)

206

120

17.04

245.45

4.1

2.8

—

COPD related to multimorbidity

667

1343

4.31

239.04

4.0

3.5

—

Bacterial Sepsis

709

1549

4.00

232.09

3.7

3.6

—

Infections, IBD-co-morbidities

304

211

10.60

229.00

7.1

3.5

—

Early onset COPD

399

716

5.76

211.76

4.3

3.5

—

Implicit bacterial Sepsis

627

1413

4.02

209.26

3.7

3.6

—

Bronchitis

1102

2397

2.92

205.92

4.3

3.6

—

Implicit bacterial Sepsis

658

1507

3.85

205.44

3.8

3.6

—

ILD medications: immunosuppressive drugs

603

1420

3.99

204.09

3.9

3.7

—

146

24.73

198.60

6.4

3.6

—

All influenza

311

470

6.75

195.54

4.5

3.4

—

Obesity related asthma

427

898

4.85

188.61

4.1

3.3

—

Infection due to other mycobacteria

121

34.15

183.32

12.6

3.5

—

Viral pneumonia

217

234

9.58

182.23

3.9

3.5

—

Fever of other and unknown origin

630

1609

3.53

176.43

3.8

3.9

—

Lung transplantation

101

66.64

175.90

5.3

3.1

—

Codes for special purposes

632

1856

3.45

175.82

4.0

3.7

—

Provisional assignment of new diseases of uncertain etiology

631

1855

3.45

175.26

4.0

3.7

—

Implicit Sepsis

830

2100

3.02

172.46

3.7

3.8

—

Chronic sinusitis

511

1322

3.93

171.97

5.2

3.6

—

Lung transplant status

64.83

171.51

5.4

3.1

—

COPD-related respiratory insufficiency

278

438

6.66

169.29

4.2

3.6

—

Symptoms and signs involving the circulatory and respiratory systems

812

1254

3.27

168.09

4.0

3.7

—

Emphysema

183

176

10.99

167.66

4.4

2.5

—

Other diseases of the respiratory system

382

811

4.86

167.61

4.0

3.5

—

Other respiratory disorders and diseases

382

811

4.86

167.61

4.0

3.5

—

Tramadol

788

1565

3.13

163.39

3.7

3.8

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

965

2494

2.69

159.88

3.8

—

Atypical mycobacterium lung infection

40.54

155.53

13.2

3.1

—

Bleeding

884

2312

2.75

153.31

3.9

3.7

—

Asthma and allergy, excluding more controls

117

20.22

151.55

4.2

2.8

—

Suppurative and necrotic conditions of lower respiratory tract

180

196

9.91

151.41

4.2

3.7

—

Asthma and allergy

117

18.91

147.12

4.2

2.8

—

Chronic rhinitis, nasopharyngitis and pharyngitis

383

905

4.31

146.19

4.0

3.6

—

Implicit Sepsis

823

2195

2.77

145.83

3.7

3.9

—

Covid-19 confirmed case

476

1330

3.65

143.74

4.0

3.6

—

Idiopathic pulmonary fibrosis

212

306

7.37

140.74

3.7

3.5

—

Continuous positive airway pressure

284

433

5.66

139.85

3.5

3.8

—

Respiratory tuberculosis, confirmed

108

21.63

139.48

12.9

3.7

—

Pain in throat and chest

650

1237

3.18

137.98

4.0

3.7

—

Implicit viral Sepsis

389

978

4.06

136.76

4.1

3.6

—

Malignant neoplasm of bronchus and lung, including Hilmo

369

718

4.42

136.56

3.1

3.7

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

108

19.78

134.09

12.9

3.7

—

Certain infectious and parasitic diseases

781

1393

2.83

128.29

4.3

3.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

812

2168

2.60

126.29

3.8

3.9

—

Tuberculosis, IBD comorbidity

190

275

7.29

125.64

9.1

3.2

—

Non-small cell lung cancer, including Hilmo

277

540

4.99

123.00

3.0

3.8

—

Tuberculosis

179

249

7.62

122.83

9.4

3.6

—

Malignant neoplasm of respiratory system and intrathoracic organs

344

689

4.27

121.61

3.0

3.8

—

Tuberculosis, wide

191

295

6.82

118.82

9.1

3.6

—

Persons encountering health services for specific procedures and health care

916

2285

2.42

118.25

4.1

3.7

—

Abscess of lung

23.15

118.10

4.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

792

2225

2.53

117.38

3.8

3.9

—

Malignant neoplasm of bronchus and lung

310

592

4.47

116.01

2.9

3.8

—

Respiratory tuberculosis, confirmed and not-confirmed

161

218

7.86

113.25

9.9

3.7

—

Respiratory tuberculosis

161

218

7.86

113.25

9.9

3.7

—

Pneumonia due to other infectious organisms, not elsewhere classified

17.79

112.52

3.6

3.3

—

Viral Sepsis

278

635

4.48

111.25

4.2

3.6

—

Implicit viral Sepsis

277

635

4.46

110.35

4.1

3.6

—

Heart failure, not strict

728

1940

2.58

110.13

3.6

3.7

—

Pleural effusion

257

558

4.75

109.89

3.5

3.4

—

Malaise and fatigue

521

1419

2.99

108.84

3.5

3.7

—

Certain infectious and parasitic diseases

561

906

3.12

108.70

4.1

3.1

—

Later onset COPD

407

954

3.47

107.09

3.7

3.4

—

Oxycodone

436

1243

3.22

106.15

3.6

3.7

—

Septicaemia

452

1395

3.07

102.69

3.5

3.3

—

Transplanted organ and tissue status

182

312

6.06

101.72

4.4

3.7

—

L04AD Calcineurin inhibitors

177

313

5.84

95.69

4.4

3.8

—

Certain disorders involving the immune mechanism

252

604

4.27

94.85

4.2

3.7

—

Implicit fungal Sepsis

145

213

7.13

94.50

4.3

3.9

—

Explicit Sepsis

461

1516

2.88

93.23

3.5

3.7

—

L04AA Selective immunosuppressants

267

677

4.02

93.03

4.1

3.7

—

Care involving use of rehabilitation procedures

579

2105

2.55

92.89

4.3

3.7

—

Heart failure,strict

559

1492

2.68

92.14

3.4

3.7

—

ILD-related respiratory insufficiency

111

124

9.76

91.85

3.5

4.2

—

Speech therapy

324

952

3.47

90.91

3.9

3.6

—

Examination and observation for other reasons

538

1126

2.79

90.65

3.9

3.7

—

Unspecified acute lower respiratory infection

211

457

4.73

90.40

4.6

3.4

—

Diseases of oesophagus, stomach and duodenum

877

2423

2.18

89.32

3.8

3.7

—

All influenza (not pneumonia)

152

247

6.26

89.25

4.7

3.4

—

All kidney diseases

807

2504

2.22

88.70

3.8

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

219

190

5.82

88.38

4.3

3.4

—

Suggestive for eosinophilic asthma

148

240

6.37

87.47

4.5

3.5

—

Erysipelas

617

1937

2.45

87.32

3.7

3.5

—

Codeine

707

1628

2.37

85.44

3.7

4.0

—

Acute sinusitis

434

1439

2.82

84.80

4.8

3.6

—

Renal tubulo-interstitial diseases

745

2513

2.22

84.12

3.6

3.8

—

Heart failure, strict

615

1802

2.44

83.80

3.5

3.6

—

Aspergillosis

24.02

82.01

6.4

4.1

—

General symptoms and signs

795

1802

2.22

80.98

3.8

4.0

—

Non-small cell lung cancer

179

373

4.91

79.66

2.8

3.7

—

Other septicaemia

383

1284

2.90

79.59

3.5

3.3

—

Any death

613

1873

2.37

79.09

3.4

3.7

—

Dental caries

267

731

3.56

77.72

4.4

3.8

—

All-cause Heart Failure

593

1781

2.38

76.77

3.5

3.6

—

Immunodeficiencies

102

128

8.37

76.40

4.9

3.7

—

Pneumocystosis

12.89

76.22

3.4

3.9

—

Other diseases of upper respiratory tract

881

2241

2.06

75.36

4.1

3.7

—

Pain in limb

659

1975

2.25

74.55

3.5

3.9

—

Pulmonary heart disease, diseases of pulmonary circulation

362

1296

2.83

72.40

3.7

3.5

—

Immunodeficiency with predominantly antibody defects

11.50

72.21

4.0

3.9

—

Anaemias

162

190

5.62

72.09

4.1

—

Exposure to unspecified factor

789

2797

2.04

71.39

3.9

3.8

—

Implicit fungal Sepsis

117

8.52

71.05

4.5

4.3

—

Fungal Sepsis

129

8.03

70.64

4.4

4.2

—

Mycoses

684

2831

2.12

70.59

3.9

3.8

—

Acute upper respiratory infections of multiple and unspecified sites

585

1922

2.27

69.57

4.3

3.7

—

Diagnoses used for exclusion with ILD

297

986

3.06

68.22

3.6

3.5

—

Simple and mucopurulent chronic bronchitis

9.05

68.07

4.5

2.5

—

Opioids

687

1645

2.18

67.78

3.6

4.0

—

Protozoal diseases

100

9.13

67.42

3.4

4.8

—

Voice disturbances

281

919

3.10

66.23

3.8

3.7

—

Other pleural conditions

158

350

4.65

66.11

3.5

3.4

—

Viral pneumonia (unknown virus, not influenza)

109

173

6.51

65.88

3.2

3.7

—

Acute upper respiratory infections

812

2535

1.98

65.63

4.3

3.7

—

Dysphagia

279

916

3.09

65.34

4.4

3.7

—

Caries of dentine

229

648

3.49

64.85

4.5

3.7

—

Pyothorax

100

149

7.08

64.53

4.0

3.8

—

Codeine or tramadol medication

866

2448

1.95

64.35

3.7

3.8

—

Pain, not elsewhere classified

252

789

3.23

63.82

3.8

—

Erysipelas

472

1783

2.36

63.81

3.6

3.4

—

Persons encountering health services in other circumstances, wide

893

2421

1.91

61.80

4.0

3.8

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

849

2403

1.93

61.58

4.0

3.8

—

Candidiasis

267

897

3.01

60.03

4.3

3.8

—

Aplastic and other anaemias

461

1878

2.31

59.87

3.4

3.6

—

Other soft tissue disorders, not elsewhere classified

693

2013

2.03

58.91

3.6

3.9

—

Viral hepatitis, IBD co-morbidity

10.72

57.79

3.6

—

Renal failure

465

1827

2.27

57.49

3.4

3.5

—

Medical observation and evaluation for suspected diseases and conditions

512

1144

2.30

57.12

3.8

3.7

—

Any reimbursement code in KELA

316

537

2.96

56.81

4.6

4.7

—

Other anaemias

429

1780

2.32

56.15

3.4

3.6

—

Other heart diseases

312

728

2.82

56.02

3.4

4.1

—

Polyarthropathies

548

1672

2.16

55.93

3.7

3.8

—

Other and unspecified anaemias

424

1768

2.31

55.22

3.4

3.6

—

All chronic kidney diseases

478

1774

2.22

55.19

3.8

3.7

—

Metabolic disorders

709

2222

1.96

55.19

3.9

3.8

—

Intestinal infectious diseases

860

2677

1.84

55.17

3.8

—

Gastro-oesophageal reflux disease

541

2244

2.09

54.51

3.8

3.7

—

Symptoms and signs involving speech and voice

313

1209

2.62

54.09

3.6

3.7

—

Any gastric operation

510

1142

2.25

53.83

4.1

3.7

—

GASTRO-related operations

510

1142

2.25

53.83

4.1

3.7

—

Other and unspecified immunodeficiencies with predominantly antibody defects

16.26

53.53

4.6

3.9

—

Other medical care

412

1623

2.30

52.87

3.8

3.5

—

Heart failure and antihypertensive medication

244

515

3.14

52.40

3.4

4.0

—

ILD medications: pirfenidone

16.38

52.00

3.4

—

Pulmonary embolism

300

1167

2.60

51.15

3.8

3.5

—

L04AX Other immunosuppressants

439

2028

2.18

50.46

3.7

3.9

—

Second line medication for Crohn's disease

446

2084

2.16

49.80

3.7

3.8

—

Unspecified privation

139

348

4.09

49.63

4.4

3.8

—

Diverticular disease of intestine

596

1921

1.99

49.41

3.6

3.7

—

Pulmonary heart disease

300

1187

2.56

49.40

3.8

3.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

392

1698

2.26

48.95

3.7

—

Osteoporosis

272

958

2.69

48.81

3.8

3.6

—

Heart failure and bmi 25plus

302

780

2.64

48.49

3.1

3.6

—

Intestinal infectious diseases

694

2857

1.85

48.13

3.9

—

Non-small cell lung cancer, adenocarcinoma

105

217

5.01

48.01

2.9

3.8

—

Covid-19 suspected case

186

578

3.26

47.87

4.2

3.8

—

Mycoses

252

931

2.74

47.68

4.6

3.5

—

Systemic connective tissue disorders

316

1305

2.45

47.48

3.7

—

Osteopathies and chondropathies

459

2056

2.10

47.04

3.8

3.7

—

Diaphragmatic hernia

341

1467

2.35

46.77

3.7

3.6

—

Venous thromboembolism

478

2266

2.05

46.71

3.8

3.7

—

Chronic gastritis

278

1091

2.58

46.63

3.6

—

Autoimmune diseases related-to ILD

582

2620

1.91

45.40

3.7

3.9

—

Diarrhoea and gastroenteritis of presumed infectious origin

522

2410

1.96

44.49

3.6

3.8

—

Constipation

675

2564

1.83

44.40

3.9

3.7

—

Complications of surgical and medical care, not elsewhere classified

728

2800

1.79

44.28

3.8

—

Ulcer of lower limb, not elsewhere classified

181

586

3.15

43.75

3.5

3.6

—

Acute renal failure

231

856

2.74

43.58

3.5

3.6

—

Invasive ventilation

102

224

4.68

43.29

3.2

3.6

—

Fall on same level

788

2455

1.76

43.18

3.6

4.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

720

2672

1.78

43.10

3.6

3.9

—

Heart failure and coronary heart disease

407

1342

2.17

43.05

3.2

3.6

—

Other heart diseases, wide

583

1868

1.92

42.99

3.4

4.1

—

ILD medications: azathioprine

116

283

4.15

42.79

4.2

3.3

—

Non-ischemic cardiomyopathy

293

969

2.46

42.60

3.6

3.7

—

Other diseases of intestines

705

2230

1.81

42.49

3.8

3.9

—

Disorders of lipoprotein metabolism and other lipidaemias

624

2090

1.86

42.02

3.4

3.8

—

Persons encountering health services for specific procedures, not carried out

100

222

4.60

41.79

3.8

3.7

—

Autoimmune diseases excluding thyroid diseases

752

2342

1.76

41.23

3.9

—

128

345

3.76

41.16

4.6

3.7

—

Other bacterial intestinal infections

213

781

2.76

40.98

4.2

3.6

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

196

453

3.02

40.58

3.8

—

Benign neoplasm of colon, rectum, anus and anal canal

533

2472

1.89

40.06

3.9

3.6

—

Cardiovascular diseases (excluding rheumatic etc)

335

832

2.33

39.88

4.4

—

Diseases of arteries, arterioles and capillaries

562

2238

1.87

39.80

3.5

3.7

—

Oedema, not elsewhere classified

263

1068

2.45

39.75

3.5

3.7

—

Liquid cancers, helper endpoint

324

1261

2.26

39.75

3.5

3.7

—

Other bacterial intestinal infections

180

614

2.97

39.66

4.2

3.5

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

105

256

4.24

39.13

2.9

3.7

—

Pain in joint

403

1224

2.11

39.12

3.9

4.2

—

Explicit bacterial Sepsis

122

332

3.74

38.78

3.3

3.8

—

Autoimmune diseases excluding thyroid diseases, strict definition

723

2277

1.75

38.71

3.8

3.9

—

Childhood asthma (age<16), excluding more controls

10.56

38.68

5.5

2.9

—

Chronic kidney disease

296

1279

2.29

38.39

3.5

—

Use of hypnotics and sedatives

749

2514

1.72

38.27

3.7

—

Bacterial intestinal infections, IBD co-morbidities

182

639

2.89

38.08

4.3

3.4

—

Viral infections characterized by skin and mucous membrane lesions

600

2887

1.78

37.88

4.0

3.8

—

Pneumothorax

205

4.55

37.44

4.8

3.6

—

Childhood asthma (age<16)

10.01

37.39

5.5

2.9

—

Substance abuse, excluding more controls

423

1822

1.99

37.36

3.9

3.8

—

Azathioprine

116

313

3.75

37.25

4.2

3.4

—

Adjustment and management of implanted device

193

710

2.76

37.02

3.4

3.5

—

Dialysis, with operation codes

144

451

3.25

36.87

3.9

3.5

—

Enlarged lymph nodes

141

437

3.27

36.60

3.8

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

352

1646

2.09

36.42

4.1

4.0

—

Hypertensive diseases (excluding secondary)

293

728

2.35

35.85

3.8

3.9

—

Bronchitis, not specified as acute or chronic

173

4.76

35.49

3.9

3.1

—

Streptococcal septicaemia

105

275

3.90

35.35

3.4

3.2

—

Allergic conjunctivitis

363

1744

2.04

35.17

4.1

4.0

—

Atrial fibrillation and flutter

220

546

2.63

34.99

3.5

4.0

—

Other disorders of skin and subcutaneous tissue

527

2605

1.81

34.95

3.7

—

Syncope and collapse

333

1354

2.12

34.88

3.5

3.7

—

Substance use, excluding alcohol

162

560

2.92

34.86

4.1

3.9

—

Parasetamol

462

1200

1.96

34.73

3.4

4.2

—

Acute tubulo-interstitial nephritis

458

2106

1.89

34.67

3.7

3.8

—

Abdominal and pelvic pain

679

1984

1.73

34.29

3.6

4.0

—

Viral pneumonia (known virus, not influenza)

7.47

34.16

4.8

3.5

—

Nasal polyp

173

627

2.79

34.15

5.3

3.6

—

Sarcoidosis

136

432

3.20

34.02

3.7

—

Special screening examination for infectious and parasitic diseases

155

373

3.08

33.94

4.2

3.8

—

Other CVD (FINNGEN)

112

233

3.78

33.72

3.6

4.0

—

Diseases of the skin and subcutaneous tissue

656

1906

1.73

33.61

4.1

3.7

—

Other necrotizing vasculopathies

254

3.96

33.58

4.7

3.9

—

Cerebrovascular diseases (FINNGEN)

205

555

2.63

33.42

3.7

4.0

—

Other necrotizing vasculopathies (FG)

199

4.39

33.38

4.4

4.0

—

Pure hypercholesterolaemia

551

2021

1.79

33.36

3.4

3.8

—

Benzodiazepine use

693

2869

1.67

33.26

3.8

3.7

—

Atrial fibrillation and flutter with reimbursement

196

461

2.73

33.16

3.2

4.0

—

DVT of lower extremities and pulmonary embolism

360

1806

2.00

33.13

3.7

3.6

—

Nephropathy related operations

136

442

3.13

32.79

3.6

—

Conjunctivitis

474

2172

1.83

32.54

4.0

—

Allergic bronchopulmonary aspergillosis (ABPA)

47.25

32.54

7.0

2.7

—

Unspecified chronic bronchitis

6.81

32.41

4.7

2.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

648

2504

1.69

32.33

3.6

3.8

—

Secondary right heart disease

152

4.91

32.24

3.5

3.6

—

Vasomotor and allergic rhinitis

225

933

2.38

32.13

4.3

3.9

—

Disorders of conjunctiva

535

2448

1.76

32.11

3.9

—

Mental and behavioural disorders due to psychoactive substance use

434

2174

1.86

31.88

3.8

—

Complications of medical and surgical care

528

2784

1.75

31.79

3.7

—

Spondylopathies

575

1973

1.75

31.73

3.6

3.8

—

Infections of the skin and subcutaneous tissue

404

2129

1.89

31.53

4.2

3.8

—

Benign neoplasm: Colon

446

2336

1.84

31.48

4.0

3.6

—

Substance abuse

423

2142

1.87

31.47

3.9

3.8

—

Symptoms and signs involving the digestive system and abdomen

666

1984

1.69

31.15

3.6

4.0

—

Other symptoms and signs involving the circulatory and respiratory systems

126

5.17

30.88

3.2

3.0

—

Vocal cord dysfunction

110

287

3.47

30.76

3.3

3.7

—

Open wound of lower leg

143

496

2.92

30.71

4.6

3.6

—

Cardiovascular diseases

288

698

2.23

30.64

4.4

4.6

—

Gout

262

1054

2.21

30.58

3.4

3.7

—

Other pulmonary heart/vessel disease

171

4.53

30.56

3.4

4.0

—

Complications of procedures, not elsewhere classified

563

2740

1.71

30.46

3.8

—

Headache

381

1590

1.92

30.23

3.9

—

Pneumonia due to Streptococcus pneumoniae

7.02

30.19

3.6

3.1

—

Paroxysmal tachycardia

152

454

2.82

29.62

3.5

4.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

220

959

2.32

29.55

3.6

—

Reimbursement for rheumatic diseases

404

2188

1.85

29.52

4.0

3.7

—

Disorders of eyelid, lacrimal system and orbit

599

2733

1.67

29.49

3.8

3.7

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

656

2739

1.64

29.36

3.8

—

Other systemic involvement of connective tissue (FG)

209

882

2.36

29.22

3.3

3.9

—

Other diseases of blood and blood-forming organs, wide

188

772

2.46

28.89

3.5

3.6

—

Abnormal findings on examination of blood, without diagnosis

380

1868

1.88

28.85

4.0

3.5

—

Emergency coronary revascularization (for ACS)

607

2221

1.67

28.47

3.3

3.8

—

Percutaneous Coronary Intervention

546

1960

1.72

28.38

3.4

3.8

—

Ischemic heart diseases

563

1996

1.70

28.30

3.5

3.8

—

Chronic viral hepatitis

118

5.11

28.04

3.7

4.1

—

Injuries to the thorax

357

1900

1.89

27.98

3.5

3.7

—

Low back pain

496

2059

1.74

27.85

3.6

3.9

—

Abnormalities of heart beat

200

840

2.35

27.76

3.4

3.6

—

Other antidepressants

697

2219

1.61

27.74

3.7

3.9

—

Cardiomyopathy

155

592

2.65

27.73

3.5

3.7

—

Factors influencing health status and contact with health services

203

408

2.51

27.42

4.3

3.7

—

Cardiac arrhythmias

334

1108

1.97

27.22

3.3

4.2

—

Other viral hepatitis

145

4.57

27.12

3.6

4.0

—

Persons encountering health services for examination and investigation

421

1144

1.85

26.99

3.7

—

Biological medicines for asthma

7.80

26.96

4.4

3.4

—

Other disorders of urethra and urinary system

473

1970

1.74

26.82

3.7

3.8

—

Pain (limb, back, neck, head abdominally)

467

1314

1.79

26.72

3.3

4.2

—

Depression medications

138

227

3.07

26.66

4.2

5.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

416

1144

1.85

26.56

4.3

3.7

—

Neoplasms

413

1193

1.84

26.37

4.2

4.0

—

Coronary revascularization (ANGIO or CABG)

537

1960

1.69

26.20

3.4

3.8

—

Spondylosis

398

1807

1.81

26.11

3.6

3.7

—

Other systemic involvement of connective tissue

216

985

2.21

26.07

3.3

3.7

—

Sleep apnoea

634

2564

1.61

26.05

3.8

—

Non-small cell lung cancer, squamous

163

4.28

25.98

2.7

3.7

—

Malignant neoplasm, wide definition for exclusion

541

1895

1.68

25.93

3.5

3.8

—

Other immunodeficiencies

10.68

25.89

6.4

4.2

—

Dermatitis and eczema

721

2877

1.56

25.83

4.0

3.8

—

Endocrine, nutritional and metabolic diseases

474

1373

1.75

25.60

3.9

4.3

—

Dorsalgia

634

2113

1.61

25.43

3.6

4.0

—

Hernia

616

2583

1.60

25.34

3.7

3.8

—

Disorders of thyroid, IBD co-morbidities

102

216

3.34

25.18

3.7

3.3

—

Hyperlipidaemia, other/unspecified

315

1536

1.90

24.85

3.3

3.8

—

Sleep disorders (combined)

732

2485

1.55

24.82

3.6

3.9

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

7.92

24.75

3.3

3.9

—

Seropositive rheumatoid arthritis

200

900

2.23

24.71

3.9

3.8

—

Other specific joint derangements/joint disorders

451

1690

1.73

24.63

3.9

4.0

—

Neurological diseases, wide definition

146

261

2.82

24.56

4.0

3.7

—

Enterocolitis due to Clostridium difficile

116

407

2.90

24.55

4.7

3.3

—

Candidiasis

116

407

2.89

24.50

5.0

3.9

—

Hard cardiovascular diseases

541

1961

1.65

24.42

3.5

3.9

—

Other arrhythmias

389

1653

1.78

24.24

3.4

4.0

—

Peripheral artery disease

371

1647

1.81

24.24

3.8

3.5

—

Gout, unspecified

198

900

2.23

24.21

3.4

3.6

—

Gout, FINNGEN

262

1323

1.99

24.01

3.4

3.5

—

Periodontitis

642

2749

1.57

23.97

3.9

3.7

—

Diseases of oral cavity, salivary glands and jaws

431

1260

1.77

23.97

3.6

3.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

232

684

2.15

23.88

4.1

3.9

—

Malignant neoplasm

521

1867

1.66

23.81

3.4

3.8

—

Gout, idiopatic and unspecified

229

1111

2.08

23.67

3.3

3.5

—

Chronic periodontitis, including avohilmo

639

2749

1.56

23.62

3.9

3.7

—

Hypertension, essential

465

1547

1.71

23.54

3.6

3.9

—

Need for immunization against other single viral diseases

7.10

23.54

5.3

4.0

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

7.34

23.53

4.3

3.7

—

Intracranial trauma

350

1350

1.83

23.47

3.5

4.2

—

Alcohol use disorder, Swedish definition

387

2043

1.75

23.18

3.8

3.7

—

Viral infections characterized by skin and mucous membrane lesions

287

1516

1.90

23.10

3.9

3.7

—

Gastrointestinal diseases

323

848

1.91

22.98

4.1

4.0

—

Anxiety disorders, excluding more controls

503

1995

1.65

22.89

4.0

3.8

—

Benign neoplasms

608

2123

1.58

22.86

4.2

3.7

—

Symptoms and signs involving the urinary system

537

2558

1.61

22.77

3.9

3.7

—

Fracture of rib(s), sternum and thoracic spine

239

1195

2.02

22.72

3.5

3.6

—

Any mental disorder

712

2338

1.53

22.53

3.9

3.8

—

Hernia of abdominal wall, postoperative

127

488

2.62

22.52

3.7

3.3

—

Atherosclerosis, excluding cerebral and coronary sclerosis

349

1548

1.80

22.49

3.6

3.5

—

Hypertensive diseases

465

1565

1.68

22.36

3.6

3.9

—

Other external causes of accidental injury

501

1517

1.66

22.24

3.6

3.8

—

Mood disorders, excluding more controls

592

2249

1.58

22.24

4.0

3.8

—

STROKE

359

1372

1.79

22.14

3.6

3.9

—

Other diseases of pericardium

131

4.38

22.12

3.7

4.4

—

Asthma mixed form (mode)

9.09

22.08

4.4

2.7

—

Other and unspecified iron deficiency

254

1313

1.95

21.89

3.7

3.6

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

424

2520

1.67

21.82

3.8

3.7

—

Shoulder lesions

501

1866

1.63

21.79

3.5

3.8

—

Hypertension

462

1565

1.67

21.69

3.6

3.9

—

Cardiodefibrillation

301

1647

1.84

21.69

3.5

3.6

—

Other diseases of urinary system

639

2333

1.54

21.69

3.6

3.8

—

Depression or dysthymia

452

1489

1.68

21.58

4.1

3.9

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

133

535

2.51

21.49

4.0

3.7

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

316

1754

1.80

21.47

3.9

3.6

—

Respiratory tuberculosis, not confirmed

157

3.99

21.27

3.8

3.9

—

Rheumatoid arthritis

237

1079

1.98

21.19

3.9

3.8

—

Other and unspecified polyneuropathies, also in other diseases

168

755

2.25

21.18

3.4

3.6

—

Other dorsopathies, not elsewhere classified

624

2116

1.55

21.10

3.6

4.0

—

Congenital malformations of the respiratory system

6.71

21.09

4.0

3.5

—

Mental and behavioural disorders due to opioids

5.59

21.08

4.2

3.8

—

Injuries to the head

697

2867

1.50

21.01

3.6

3.9

—

Finngen Rheumatological endpoints

575

2091

1.57

20.99

3.6

3.9

—

Major coronary heart disease event

555

2131

1.58

20.99

3.4

3.8

—

Rotator cuff syndrome

413

1767

1.68

20.94

3.4

3.8

—

Sequelae of tuberculosis

5.92

20.88

6.4

3.5

—

Polyneuropathies and other disorders of the peripheral nervous system

185

869

2.15

20.88

3.4

3.6

—

Nonhereditary hypogammaglobulinemia

9.21

20.88

4.3

3.9

—

Congenital malformations of the respiratory system

6.40

20.80

3.9

3.7

—

Falls/tendency to fall

650

2131

1.53

20.78

3.4

4.0

—

Mental and behavioural disorders due to alcohol

347

1928

1.74

20.73

3.8

3.7

—

Viral hepatitis

187

3.64

20.72

3.5

4.3

—

Iron deficiency anaemia

312

1727

1.79

20.69

3.6

—

Other and unspecified dermatitis

339

1952

1.75

20.67

4.0

3.7

—

Cardiomyopathy, other and unspecified

256

3.22

20.65

3.4

4.1

—

Pulmonary eosinophilia, not elsewhere classified

7.89

20.60

4.1

3.9

—

Other disorders of fluid, electrolyte and acid-base balance

237

1163

1.95

20.54

3.6

3.7

—

Lung diseases due to external agents

141

596

2.40

20.54

3.7

3.5

—

Human immunodeficiency virus [HIV] disease

6.29

20.47

4.3

3.6

—

395

2139

1.68

20.47

3.8

—

Sleep apnoea, including avohilmo

638

2612

1.52

20.44

3.8

—

409

2180

1.66

20.32

3.7

3.8

—

Follow-up examination after treatment for conditions other than malignant neoplasms

266

927

1.91

20.10

3.5

3.6

—

Cellulitis

164

746

2.22

20.06

4.4

3.7

—

Pneumonia derived septicemia

5.13

20.06

3.8

3.1

—

Any event in cancer register

539

2025

1.57

20.04

3.5

3.8

—

Sulfasalazine

159

714

2.24

20.02

3.4

—

Gingivitis and periodontal diseases

660

2261

1.51

19.95

3.8

3.7

—

Congenital malformations of trachea and bronchus

8.71

19.90

3.8

3.6

—

Soft tissue disorders

607

2039

1.54

19.87

3.7

4.0

—

Accidents

489

1517

1.62

19.83

3.6

3.8

—

Need for other prophylactic measures

170

3.72

19.73

4.2

3.5

—

L01XE Protein kinase inhibitors

194

3.54

19.71

3.4

3.9

—

Seropositive rheumatoid arthritis, strict definition

122

492

2.51

19.69

4.0

3.7

—

Symptoms and signs involving the skin and subcutaneous tissue

453

2786

1.60

19.64

3.9

3.8

—

Type 2 diabetes, wide definition

549

2272

1.55

19.63

3.3

3.9

—

Dermatitis

396

2408

1.65

19.43

4.0

3.8

—

Seropositive rheumatoid arthritis, wide

200

994

2.03

19.43

3.9

3.6

—

Other/unspecified seropositive rheumatoid arthritis

198

982

2.03

19.35

3.9

3.6

—

Depression

574

2557

1.53

19.22

4.0

3.8

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

138

595

2.34

19.19

4.0

3.6

—

Other functional intestinal disorders

302

1591

1.77

19.16

3.8

—

Methotrexate

322

2.85

19.00

3.5

3.4

—

Lower back pain or/and sciatica

656

2901

1.48

18.94

3.6

3.8

—

Allergic rhinitis

168

780

2.14

18.91

3.7

4.2

—

Nutritional anaemias

356

2052

1.68

18.86

3.7

3.6

—

Anxiety disorders

520

2344

1.55

18.85

4.0

3.9

—

Persons with potential health hazards related to communicable diseases

196

968

2.02

18.82

4.6

4.1

—

Non-small cell lung cancer, squamous, helper endpoint

205

3.40

18.81

2.8

3.6

—

Problems related to lifestyle

260

3.07

18.79

3.7

3.6

—

Convulsions, not elsewhere classified

144

631

2.27

18.65

3.7

3.8

—

Cystic fibrosis

47.54

18.62

17.6

2.3

—

Chronic periodontitis, complicated

374

2256

1.65

18.59

3.8

3.7

—

Chronic lymphocytic leukaemia

4.64

18.59

3.4

4.3

—

Chronic lymphocytic leukaemia, helper endpoint

4.64

18.59

3.4

4.3

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.64

18.59

3.4

4.3

—

Episodal and paroxysmal disorders

662

2272

1.49

18.55

3.7

3.9

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

193

965

2.02

18.47

3.8

3.6

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

150

3.78

18.40

3.5

4.1

—

Sequelae of external causes of morbidity and mortality

191

954

2.02

18.34

3.5

3.6

—

Alcohol dependence

196

988

2.00

18.33

3.7

3.6

—

Spinal stenosis

372

1705

1.67

18.31

3.7

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

338

1344

1.71

18.17

3.7

3.8

—

Disorders of lens

455

1790

1.59

18.14

3.3

3.8

—

Poisoning by drugs, medicaments and biological substances

144

648

2.24

18.11

3.4

4.2

—

Other/unspecified dorsalgia

244

1316

1.85

18.07

3.5

3.8

—

Other infectious diseases

321

2.81

18.03

3.6

3.5

—

Neurotic, stress-related and somatoform disorders

511

2328

1.54

18.02

4.0

3.9

—

Anxiety (asthma-related co-morbidities)

316

1419

1.73

17.99

4.1

4.0

—

Solid cancers, helper endpoint

489

1851

1.56

17.90

3.4

3.8

—

Chronic laryngitis and laryngotracheitis

104

408

2.57

17.82

4.4

3.6

—

ILD medications: nintedanib

16.99

17.78

3.5

3.3

—

Other noninfective gastroenteritis and colitis

170

824

2.08

17.68

4.3

3.8

—

Other CVD

174

853

2.06

17.63

3.6

3.5

—

Symptoms and signs concerning food and fluid intake

308

2.82

17.57

3.7

3.8

—

Mood [affective] disorders

616

2711

1.48

17.56

4.0

3.8

—

Hypotension

158

749

2.13

17.52

3.4

—

Mood disorders

617

2714

1.47

17.49

4.0

3.8

—

Drug-induced osteoporosis with pathological fracture

5.89

17.45

3.4

—

Cutaneous abscess, furuncle and carbuncle

170

830

2.06

17.39

4.2

3.7

—

Deviated nasal septum

212

1117

1.91

17.36

3.6

3.5

—

Valvular heart disease excluding rheumatic fever

302

1260

1.74

17.32

3.7

3.8

—

Other viral diseases

202

1041

1.93

17.28

3.4

4.0

—

Non-Hodgkin lymphoma, all, including Hilmo

111

457

2.46

17.21

3.3

3.9

—

Non-rheumatic valve diseases

301

1257

1.74

17.16

3.7

3.8

—

Benign neoplasm: Colon, unspecified

204

1068

1.93

17.15

3.9

3.5

—

Osteoporosis with pathological fracture (FG)

217

3.19

17.13

3.6

—

Concussion

286

1342

1.75

17.05

3.6

4.1

—

Diseases of the musculoskeletal system and connective tissue

288

807

1.80

17.01

3.7

4.4

—

Other arthritis (FG)

205

1078

1.91

16.96

3.8

—

Chronic apical periodontitis

686

2716

1.44

16.92

3.8

3.9

—

Nausea and vomiting

180

889

2.00

16.79

4.4

4.0

—

Other gastritis (incl. Duodenitis)

167

823

2.05

16.69

3.6

3.5

—

Hypothyroidism and >3 levothyroxin purchases

202

2.75

16.64

3.5

4.2

—

Hypothyroidism, levothyroxine purchases

202

2.75

16.64

3.5

4.2

—

Cerebrovascular diseases

512

2390

1.51

16.57

3.6

3.7

—

Other anxiety disorders

236

1124

1.83

16.57

4.0

4.1

—

Endocarditis

103

4.27

16.55

3.2

4.1

—

Psychiatric diseases

620

2116

1.47

16.53

3.8

3.9

—

Cystitis

519

2044

1.51

16.48

3.4

3.8

—

Zoster [herpes zoster]

337

2032

1.64

16.40

4.0

3.7

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

282

2.85

16.37

3.7

3.4

—

Pleural plaque

362

2.61

16.29

3.6

3.4

—

Functional dyspepsia

173

871

2.00

16.29

3.7

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

611

2695

1.46

16.23

3.8

3.7

—

Conduction disorders

207

889

1.90

16.17

3.3

3.7

—

Hypothyroidism (congenital or acquired)

202

2.72

16.15

3.5

4.2

—

Other infectious diseases

285

2.82

16.06

3.6

—

Cardiomyopathies, Primary/intrinsic

401

2.50

15.93

3.6

3.9

—

Hypertensive heart and/or renal disease

207

819

1.90

15.92

3.6

3.7

—

Disorders of oesophagus in diseases classified elsewhere

5.18

15.85

5.9

3.9

—

Fracture of lumbar spine and pelvis

171

867

1.99

15.75

3.5

3.6

—

Other disorders of veins

266

1540

1.73

15.74

3.7

3.8

—

Other cataract

317

1449

1.66

15.67

3.7

—

Poisoning by medicine

126

571

2.22

15.66

3.4

4.1

—

Alcohol use disorder, ICD-based

279

1649

1.70

15.66

3.8

3.7

—

Sequelae with surgical and medical care as external cause

153

749

2.06

15.63

3.5

3.6

—

Diseases of liver

236

1334

1.78

15.54

3.4

3.7

—

Kidney transplant status

159

3.46

15.53

4.4

4.5

—

Autoimmune diseases

660

2346

1.43

15.51

3.8

3.9

—

External causes of morbidity and mortality

377

1169

1.62

15.50

4.0

3.9

—

All anxiety disorders

317

1519

1.65

15.50

4.0

—

In situ neoplasms

266

1557

1.72

15.49

4.2

3.6

—

Non-selective monoamine reuptake inhibitors

249

1377

1.75

15.46

3.7

—

Diseases of the digestive system

322

1973

1.63

15.41

4.1

3.6

—

Pericarditis

4.25

15.36

3.4

4.3

—

Other disorders of white blood cells

175

3.32

15.35

4.0

—

Respiratory tuberculosis, clinically confirmed

6.32

15.27

4.6

3.4

—

Myocarditis

4.46

15.19

3.5

4.1

—

Cardiomyopathy (excluding other)

101

423

2.41

15.14

3.6

3.8

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

379

2433

1.56

15.14

3.8

3.7

—

Unspecified haematuria

308

1552

1.65

15.11

4.0

3.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

266

1550

1.71

15.10

3.5

3.7

—

Kela reimbursement Agammaglobulinemia (D80-84)

14.19

14.97

4.6

3.2

—

Irritable bowel syndrome

162

822

1.98

14.95

3.5

3.9

—

Other viral diseases

164

833

1.97

14.95

3.6

4.1

—

Atopic dermatitis

298

1474

1.66

14.95

4.1

3.9

—

Senile cataract

421

1672

1.55

14.94

3.3

3.8

—

Angina pectoris

388

1652

1.57

14.93

3.2

3.8

—

Dizziness and giddiness

472

2510

1.50

14.92

3.5

3.8

—

Unspecified kidney failure

415

2.42

14.86

3.0

3.6

—

Neurological diseases

488

1630

1.51

14.75

3.7

4.1

—

Sicca syndrome [Sjögren]

248

2.86

14.73

3.8

3.7

—

Diseases of the eye and adnexa

423

1368

1.55

14.60

3.8

4.1

—

Other diseases of hard tissues of teeth

380

1241

1.59

14.57

3.6

3.7

—

Polyuria

171

894

1.93

14.52

3.5

3.4

—

Injuries to the knee and lower leg

710

2834

1.39

14.50

3.7

3.9

—

Sequelae of infectious and parasitic diseases

240

2.87

14.42

5.7

3.8

—

Chronic pancreatitis

106

465

2.31

14.35

6.0

3.7

—

Recurrent or chronic depression

215

836

1.82

14.32

4.2

—

Other viral diseases, not elsewhere classified

150

749

2.00

14.27

3.4

4.1

—

Noninfective enteritis and colitis

281

1704

1.65

14.26

4.0

3.8

—

Ischaemic heart disease, wide definition

494

2074

1.48

14.26

3.4

3.8

—

Personality disorders, excluding more controls

129

613

2.11

14.25

3.4

4.2

—

Asthma mixed form (mode), excluding more controls

10.48

14.21

4.4

2.8

—

Other specified/unspecified arthritis

178

951

1.88

14.14

3.8

3.9

—

Atopic dermatitis, strict definition with reimbursement

144

691

2.02

14.02

3.8

4.0

—

Injuries to the hip and thigh

332

1905

1.59

13.98

3.6

3.7

—

Non-invasive ventilation

125

524

2.14

13.97

4.3

3.9

—

Other headache syndromes

234

1360

1.73

13.96

4.3

3.9

—

Rheumatoid arthritis, including avohilmo

251

1490

1.69

13.94

3.9

3.6

—

Used for control exclusion in common control thyroid runs

616

2192

1.42

13.94

3.7

3.9

—

Abnormal results of function studies

196

3.04

13.93

3.8

3.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

305

1285

1.64

13.91

3.7

—

Budesonide

291

2.63

13.77

3.8

3.4

—

Soft tissue disorders related to use, overuse and pressure

180

975

1.86

13.71

3.8

—

Care involving dialysis

259

2.74

13.62

5.0

3.6

—

Viral warts

125

599

2.10

13.56

4.0

—

GI-bleeding

237

1396

1.71

13.56

3.6

3.5

—

Wegener granulomatosis

5.40

13.56

6.1

3.7

—

Other diseases of the digestive system

236

1391

1.71

13.48

3.6

3.5

—

Disorders of skin appendages

265

1608

1.65

13.46

4.4

3.8

—

Other diseases of oesophagus

342

2.49

13.46

3.9

3.7

—

Nonorganic sleeping disorders, excluding more controls

108

490

2.22

13.46

3.8

4.0

—

Cytomegalovirus infection, IBD co-morbidity

4.97

13.40

3.1

3.6

—

Major coronary heart disease event excluding revascularizations

408

1801

1.52

13.39

3.3

3.8

—

Pneumococcal septicemia

107

3.82

13.32

3.7

3.9

—

Noninfectious colitis NAS

436

2.29

13.29

3.6

3.8

—

Other intervertebral disc disorders

492

2035

1.46

13.22

3.7

3.8

—

Disorders of gallbladder, biliary tract and pancreas

611

2761

1.40

13.13

3.9

3.7

—

Abnormal findings on diagnostic imaging of other body structures

336

2.46

12.95

5.5

3.3

—

Ethmoidectomy

385

2.36

12.93

6.0

3.6

—

Hypertensive Heart Disease

182

780

1.84

12.92

3.7

—

Abnormal weight loss

331

2.48

12.91

3.8

3.7

—

Overexertion and strenuous or repetitive movements

302

2.54

12.83

3.5

3.9

—

Non-Hodgkin lymphoma, all

149

3.29

12.78

2.9

3.9

—

Other inflammation of eyelid

431

2.27

12.77

3.5

3.7

—

Ptosis of eyelid

394

2.34

12.75

4.1

3.6

—

Diseases of salivary glands

196

1115

1.77

12.73

3.8

3.7

—

Adverse effects, not elsewhere classified

119

574

2.09

12.73

3.5

4.1

—

Dorsopathies

587

2121

1.41

12.68

3.6

4.0

—

Dermatophytosis

360

2383

1.51

12.61

3.5

3.7

—

Disorders of lacrimal system

258

1584

1.63

12.49

3.8

3.7

—

Other diseases of anus and rectum

200

1149

1.75

12.47

3.8

3.7

—

Weight loss

355

2.39

12.45

3.8

—

Coagulation defects, purpura and other haemorrhagic conditions

131

662

1.99

12.36

3.3

3.8

—

Obesity, other/unspecified

182

1023

1.79

12.32

3.1

3.9

—

Hypo-osmolality and hyponatraemia

130

653

2.00

12.28

3.6

3.7

—

Other viral diseases, not elsewhere classified

112

534

2.11

12.27

3.7

4.0

—

Carrier of infectious disease

4.46

12.22

5.5

3.3

—

Other disorders of lacrimal gland

213

1257

1.70

12.17

3.6

3.8

—

Pollen allergy

372

2.32

12.11

4.0

4.4

—

Disorder of lipoprotein metabolism, unspecified

105

493

2.15

12.11

3.0

3.7

—

Cytomegaloviral disease

4.40

12.02

3.1

4.0

—

Selective serotonin reuptake inhibitors

591

2221

1.39

11.99

3.8

3.9

—

Herpesviral [herpes simplex] infections

135

697

1.95

11.97

4.6

3.8

—

Coronary atherosclerosis

408

1749

1.48

11.96

3.5

3.8

—

Mental and behavioural disorders due to sedatives or hypnotics

176

2.99

11.95

3.4

4.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

132

675

1.96

11.87

3.8

4.1

—

AV-block

130

578

1.98

11.87

3.0

3.7

—

Other nutritional deficiencies

358

2259

1.50

11.80

3.4

3.8

—

Fibromyalgia

188

2.90

11.79

3.3

3.7

—

Visual disturbances

296

1910

1.56

11.78

4.0

3.8

—

Injury, poisoning and certain other consequences of external causes

297

933

1.60

11.77

4.0

—

Other disorders of eye and adnexa

421

2.23

11.74

4.9

3.9

—

Benign neoplasm of other and ill-defined parts of digestive system

130

668

1.96

11.74

3.8

3.6

—

Other arthrosis

330

1493

1.54

11.72

3.5

3.7

—

Lymphoid leukaemia

206

2.81

11.68

3.8

3.9

—

Other and unspecified disorders of white blood cells

132

3.32

11.68

3.9

3.7

—

Stomatitis and related lesions

122

614

2.00

11.67

3.5

3.9

—

Carcinoma in situ of skin of other and unspecified parts of face

373

2.31

11.63

4.6

3.6

—

Missing teeth due to accident, extraction or parodontitis

386

2483

1.47

11.63

3.6

3.7

—

Malignant neoplasm of skin

312

1382

1.55

11.61

3.7

3.8

—

Gout, strict definition

149

805

1.87

11.58

3.2

3.6

—

Abnormalities of gait and mobility

100

471

2.15

11.48

3.1

3.6

—

Non-allergic asthma

259

2.57

11.46

3.9

4.2

—

Other diseases of lip and oral mucosa

237

1463

1.63

11.41

3.6

3.7

—

Other disorders of eyelid

300

1861

1.54

11.37

3.8

3.6

—

Sequelae of injuries, of poisoning and of other consequences of external causes

144

774

1.87

11.34

3.6

3.9

—

Genitourinary diseases

335

1093

1.54

11.34

4.1

—

Unspecified fall

313

2033

1.52

11.29

3.7

3.8

—

FESS (DNB20)

371

2.28

11.28

5.9

3.6

—

Respiratory disorders in diseases classified elsewhere

5.19

11.10

7.6

4.0

—

Progressive vascular leukoencephalopathy

147

3.13

11.08

2.8

3.6

—

Other and unspecified effects of external causes

148

809

1.84

11.05

3.8

4.0

—

Hereditary hypogammaglobulinemia

19.99

11.04

5.1

3.0

—

Secondary hypertension

155

3.02

11.03

3.5

—

Conjunctivitis (acute, non atopic)

153

843

1.82

11.00

3.7

3.9

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

289

2.45

10.97

3.6

4.0

—

Acetic acid derivatives and related substances

189

557

1.77

10.94

3.3

4.4

—

Polypectomy (DHB20)

237

2.61

10.88

4.5

3.7

—

Tuberculosis of other organs

4.06

10.84

5.7

3.5

—

Injuries to the wrist and hand

568

2889

1.36

10.82

4.1

3.8

—

Other reaction to severe stress, and adjustment disorders

173

998

1.74

10.77

4.6

4.0

—

Glomerular diseases

126

661

1.92

10.74

4.1

3.4

—

Visual disturbances and blindness

313

2087

1.50

10.73

4.1

3.7

—

Basal cell carcinoma

282

1258

1.56

10.70

3.7

—

Other/unspecified cytomegaloviral diseases

4.46

10.59

3.3

3.8

—

Other disorders of adrenal gland

120

3.30

10.56

4.9

3.6

—

Antihypertensive medication - note that there are other indications

256

846

1.61

10.55

4.6

4.7

—

Paralytic ileus and intestinal obstruction

172

997

1.73

10.55

3.8

3.5

—

Other disorders of the musculoskeletal system and connective tissue

107

535

2.02

10.50

3.1

3.7

—

Fentanyl

338

2.29

10.48

3.1

3.9

—

Other or ill-defined heart diseases

152

3.00

10.42

3.5

4.6

—

Zoster [herpes zoster]

126

669

1.90

10.37

4.0

3.6

—

Basal cell carcinoma, including avohilmo

287

1289

1.54

10.36

3.8

3.7

—

Disturbances of skin sensation

149

835

1.79

10.29

3.7

3.8

—

Atopic dermatitis, strict definition

130

684

1.87

10.25

3.9

4.5

—

Cervicalgia

127

679

1.88

10.23

3.4

3.9

—

Disorders of synovium and tendon

287

1659

1.52

10.17

3.6

3.9

—

Open wound of head

336

2217

1.47

10.09

3.5

3.8

—

Any operation in hilmo

12.00

10.04

4.2

8.8

—

Other neurological diseases

459

2601

1.39

10.04

3.4

3.7

—

Cervical disc disorders

221

1387

1.60

10.01

3.9

—

Other and unspecified drugs and medicaments

271

2.42

10.01

3.3

3.9

—

Follicular cysts of skin and subcutaneous tissue

117

614

1.92

9.99

4.4

3.7

—

Transport accidents

233

1267

1.59

9.99

3.9

—

Other complications of surgical and medical care, not elsewhere classified

302

2.34

9.98

4.3

4.0

—

Recurrent aphthous stomatitis , including avohilmo

444

2.09

9.95

3.6

3.9

—

Oesophagitis

184

2.76

9.95

4.5

3.8

—

Other superficial mycoses

266

2.43

9.91

4.1

3.9

—

Diabetes, varying definitions

576

2512

1.35

9.86

3.5

4.0

—

Heart failure and hypertrophic cardiomyopathy

4.10

9.86

3.3

3.6

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

458

2.06

9.85

4.4

3.6

—

295

1812

1.50

9.85

3.9

3.6

—

Pain in thoracic spine

446

2.08

9.83

3.6

4.0

—

Memory loss

375

2.19

9.80

3.7

3.6

—

Other and unspecified coagulation defects

121

3.18

9.75

3.2

3.7

—

Myocardial infarction

317

1506

1.49

9.75

3.3

3.8

—

Tuberculosis of other organs, strict

3.65

9.72

5.6

3.4

—

Volume depletion

331

2.26

9.71

3.5

3.7

—

Trochanteric bursitis

449

2.06

9.68

3.8

—

Herpesviral [herpes simplex] infections

338

2.24

9.66

3.8

3.9

—

Dental caries, including avohilmo

463

1701

1.40

9.62

3.5

3.7

—

Personality disorders

129

707

1.83

9.62

3.4

4.1

—

Injuries to the shoulder and upper arm

497

2949

1.36

9.59

3.5

3.9

—

Benign neoplasm: Sigmoid colon

136

760

1.80

9.56

3.8

3.6

—

Suicide or other Intentional self-harm

129

709

1.83

9.54

3.8

4.0

—

Squamous cell neoplasms and carcinomas of the skin

296

2.32

9.52

4.6

3.6

—

5-aminosalicylic acid

472

2.02

9.50

3.5

3.7

—

Presence of cardiac and vascular implants and grafts

318

1610

1.47

9.49

3.2

3.6

—

Other symptoms and signs involving cognitive functions and awareness

306

1895

1.48

9.48

3.4

3.7

—

Sciatica+with lumbago

282

1736

1.50

9.47

3.7

3.8

—

Disorders of other endocrine glands

243

1553

1.54

9.46

3.9

—

Intestinal adhesions without obstruction

285

2.34

9.43

3.8

—

Discitis, unspecified

4.62

9.37

2.9

4.2

—

Adrenocortical insufficiency

104

3.33

9.34

5.3

3.6

—

Sequelae of injuries of lower limb

274

2.36

9.32

3.2

4.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

250

2.42

9.28

2.9

4.2

—

Actinic keratosis

275

1704

1.50

9.28

3.9

3.5

—

Subjective visual disturbances

150

870

1.73

9.27

3.5

3.7

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

110

582

1.91

9.23

4.1

3.6

—

Giant cell arteritis

158

2.84

9.22

3.6

3.5

—

Exposure to other specified factors

404

2667

1.39

9.21

3.7

3.9

—

Diabetes mellitus

573

2517

1.33

9.20

3.6

4.0

—

Obesity

327

2189

1.45

9.20

3.3

3.8

—

Skin changes due to chronic exposure to nonionizing radiation

280

1738

1.49

9.19

3.9

3.5

—

Obesity and other hyperalimentation

329

2202

1.44

9.19

3.3

3.8

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

181

2.70

9.16

3.2

3.9

—

Migraine with aura

108

569

1.91

9.13

4.9

4.2

—

Ocular pain

222

2.50

9.11

5.4

3.5

—

Insulin medication

371

2214

1.41

9.07

3.5

3.9

—

Eosinophilic disease (BM)

15.89

9.07

4.4

2.9

—

Pyogenic arthritis

241

2.43

9.05

3.4

4.2

—

Haemorrhage, not elsewhere classified

127

3.04

9.03

3.9

3.2

—

Mental and behavioural disorders due to tobacco

266

2.35

9.00

4.5

4.0

—

Nonorganic sleeping disorders

108

573

1.89

8.96

3.8

4.1

—

Defects in the complement system

11.28

8.92

4.8

3.6

—

Other specified/unspecified systemic involvement of connective tissue

172

2.71

8.91

3.1

3.6

—

Temporal arteritis

139

2.94

8.91

3.7

3.5

—

Benign neoplasm: Other and unspecified parts of small intestine

4.13

8.87

5.8

3.9

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

410

2.06

8.86

3.6

4.1

—

Carcinoma in situ of skin

360

2.14

8.73

4.2

3.6

—

Statin medication

354

1393

1.43

8.73

4.1

4.0

—

Smoking dependency

270

2.32

8.72

4.5

4.0

—

Nerve, nerve root and plexus disorders

615

2888

1.31

8.68

3.5

3.8

—

Reactive arthropathies, FINNGEN

198

2.55

8.64

4.5

4.1

—

Other inflammatory liver diseases

210

2.50

8.64

3.1

3.9

—

Caries of dentine, including avohilmo

482

1815

1.36

8.62

3.6

3.8

—

Extracorporeal dialysis

211

2.50

8.57

4.9

4.1

—

Somatoform disorder

477

1.96

8.56

3.2

4.1

—

Gastroduodenal ulcer

174

1070

1.63

8.56

3.5

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

3.38

8.51

4.4

3.8

—

Fracture of femur

192

1098

1.59

8.51

3.3

3.6

—

Lumbar disc prolapse

349

1897

1.41

8.50

3.7

3.8

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

116

3.08

8.48

3.3

3.4

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

155

2.76

8.39

2.9

3.9

—

Other specified/unspecified bacterial intestinal infections

214

2.46

8.32

3.4

3.3

—

N06DA Anticholinesterases

101

1442

0.55

8.30

3.7

3.5

—

Use of anticholinesterases

101

1442

0.55

8.30

3.7

3.5

—

Type 2 diabetes

554

2460

1.32

8.29

3.4

3.9

—

Drug-induced osteoporosis

4.35

8.28

3.5

3.9

—

Giant cell arteritis with polymyalgia rheumatica

145

2.81

8.28

3.7

3.6

—

Intracranial injury

337

2270

1.41

8.24

3.5

3.9

—

Superficial injury of thorax

526

1.89

8.24

3.4

3.7

—

Ischaemic Stroke, excluding all haemorrhages

378

2033

1.39

8.22

3.5

3.6

—

Sequelae of other external causes

168

2.65

8.21

3.4

4.0

—

Preparatory care for dialysis

157

2.72

8.19

4.0

—

Injuries to unspecified part of trunk, limb or body region

349

2.11

8.19

3.8

3.9

—

Intracranial and intraspinal abscess and granuloma

4.90

8.19

2.9

3.6

—

Other bacterial agents as the cause of diseases classified to other chapters

4.89

8.18

10.1

3.8

—

Selective deficiency of immunoglobulin G [IgG] subclasses

9.40

8.17

4.8

3.8

—

Injuries to the ankle and foot

348

2216

1.40

8.15

4.0

3.9

—

Myalgia

125

716

1.75

8.13

3.8

—

Retention of urine

236

1289

1.51

8.11

4.0

3.4

—

Other disorders of ear

540

2695

1.31

8.09

4.3

3.7

—

Benign neoplasm: Rectum, anus and anal canal

136

800

1.71

8.07

3.3

3.6

—

Disorders of adult personality and behaviour

129

747

1.73

8.07

3.3

4.2

—

Papulosquamous disorders

225

1495

1.51

8.02

3.5

3.7

—

Special screening examination for neoplasms

176

2.58

8.01

4.2

3.3

—

SLE (Finngen)

104

3.13

8.01

2.5

4.0

—

Osteonecrosis

200

2.48

7.99

4.3

3.4

—

Mixed connective tissue disease

188

2.53

7.99

4.0

3.6

—

Urticaria and erythema

182

1156

1.58

7.94

4.1

3.8

—

Diseases of pulp and periapical tissues, including avohilmo

601

2401

1.30

7.92

3.8

3.9

—

Other embolism and thrombosis

463

1.94

7.92

3.4

3.7

—

Alcohol-induced chronic pancreatitis

226

2.37

7.87

3.2

4.1

—

Superficial injury of lower leg

134

791

1.70

7.84

3.5

4.0

—

Unspecified human immunodeficiency virus [HIV] disease

6.62

7.82

5.2

3.4

—

Fracture at wrist and hand level

184

1175

1.57

7.79

4.1

3.9

—

Other orthopaedic follow-up care

161

2.64

7.79

3.7

3.9

—

Benign neoplasm: Small intestine

150

2.71

7.78

5.2

3.4

—

Systemic lupus erythematosus

106

3.07

7.76

2.5

3.7

—

Abnormal serum enzyme levels

207

1328

1.53

7.71

4.2

3.5

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

112

2.99

7.69

4.5

3.7

—

Infections with a predominantly sexual mode of transmission

155

888

1.63

7.66

3.9

4.4

—

Other diseases of intestine

497

1.88

7.64

3.9

3.7

—

Radiculopathy

105

583

1.81

7.63

3.4

3.7

—

SLE, strict definition

102

3.09

7.61

2.5

3.4

—

SLE, ICD10

102

3.09

7.61

2.5

3.4

—

Multiple myeloma, including Hilmo

146

2.71

7.60

2.7

3.9

—

Fall on same level involving ice and snow

319

2289

1.40

7.58

3.6

3.8

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

532

2457

1.31

7.58

3.4

4.0

—

Hypothyroidism, drug reimbursement

140

2.48

7.50

3.2

4.0

—

Congenital malformations, deformations and chromosomal abnormalities

274

1824

1.43

7.49

3.8

4.0

—

Fenamates

327

1.92

7.46

3.6

4.2

—

Glomerulonephritis

342

2.06

7.46

3.5

3.7

—

Other specified and unspecified personality disorders

213

2.36

7.43

3.6

4.3

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

17.57

7.43

5.0

3.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

132

788

1.68

7.43

3.8

4.0

—

Stroke, excluding SAH

390

2105

1.36

7.39

3.5

3.7

—

Biological medication for rheuma

467

1.89

7.39

3.8

4.3

—

Dilated cardiomyopathy

489

1.88

7.38

3.6

3.7

—

Lesion of lateral popliteal nerve

160

2.60

7.37

3.2

4.4

—

Stroke, including SAH

404

2180

1.35

7.35

3.5

3.7

—

Unstable angina pectoris

243

1310

1.47

7.33

3.4

3.6

—

Other extrapyramidal and movement disorders in other diseases

143

879

1.64

7.22

3.9

3.5

—

Other diseases of liver

104

587

1.78

7.19

3.2

3.7

—

Pneumonitis due to solids and liquids

327

2.07

7.19

3.9

3.5

—

Pain and other conditions associated with female genital organs and menstrual cycle

399

1.92

7.18

4.0

4.2

—

Gastric ulcer

117

684

1.72

7.15

3.5

—

Type 2 diabetes, definitions combined

533

2418

1.30

7.15

3.4

3.9

—

Other general symptoms and signs

110

2.91

7.15

3.6

3.3

—

Rash and other nonspecific skin eruption

301

2.11

7.14

3.7

4.0

—

Peripheral arterial reconstruction

129

776

1.67

7.11

3.3

3.6

—

Benign neoplasm: Transverse colon

432

1.92

7.09

3.6

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

15.13

7.06

5.0

3.1

—

Vascular disorders of the intestines

257

2.20

7.03

3.2

3.7

—

Biomechanical lesions, not elsewhere classified

164

2.53

7.03

3.1

3.6

—

Drug-induced adrenocortical insufficiency

3.77

6.96

4.3

3.5

—

Assault

324

2.05

6.95

4.6

4.4

—

Other specified/unspecified necrotizing vasculopathies

4.07

6.95

4.6

3.9

—

Other or unspecified immunodeficiency

11.82

6.95

8.9

4.5

—

Haemolytic anaemias

108

2.91

6.93

3.1

3.7

—

Myocardial infarction, strict

284

1435

1.41

6.91

3.3

3.7

—

Deforming dorsopathies

148

928

1.60

6.90

3.9

—

Common variable immunodeficiency

9.77

6.88

4.5

3.7

—

Hypertension, Pulmonary Arterial

6.34

6.87

3.3

—

Type 2 diabetes, definitions combined, including avohilmo

533

2412

1.29

6.86

3.5

3.9

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

3.86

6.85

2.8

3.5

—

Type 2 diabetes, strict (exclude DM1)

535

2444

1.29

6.84

3.4

3.9

—

Diabetes medication

567

2637

1.28

6.81

3.5

3.9

—

Migraine

209

1142

1.49

6.81

4.1

—

Other/unspecified reactive arthropathies

197

2.36

6.81

4.6

4.0

—

Superficial injury of head

134

823

1.63

6.80

3.4

3.8

—

Dementia in Alzheimer disease

787

0.44

6.80

3.1

3.5

—

Disorders resulting from impaired renal tubular function

126

2.74

6.80

3.4

4.4

—

Acute pharyngitis

324

2.03

6.79

3.3

3.8

—

Benign neoplasm: Rectum

120

718

1.68

6.77

3.4

3.5

—

Hypoparathyroidism

132

2.70

6.77

4.1

3.6

—

Transient ischemic attack

339

2020

1.36

6.76

3.3

3.6

—

Otitis externa

120

718

1.68

6.76

3.4

3.8

—

Other and unspecified tonsillitis

125

631

1.67

6.74

3.7

4.0

—

Other or unspecified ileus, impaction or obstruction

115

681

1.70

6.73

4.0

3.5

—

Other disorders of kidney and ureter

490

1.83

6.72

3.4

3.7

—

Non-follicular lymphoma

384

1.95

6.72

3.3

3.7

—

Insulin, combination of fast acting with intermediate-acting or long-acting

371

2539

1.34

6.71

3.5

3.8

—

Behavioural syndromes associated with physiological disturbances and physical factors

477

2610

1.30

6.71

3.6

4.0

—

Infections with a predominantly sexual mode of transmission

126

765

1.65

6.66

4.1

4.2

—

Melanocytic naevi

151

961

1.58

6.64

3.8

3.7

—

Agranulocytosis

365

1.96

6.61

3.2

3.9

—

Striking against or struck by other objects

166

1081

1.54

6.56

4.3

4.1

—

Diseases of the ear and mastoid process

627

2502

1.26

6.56

4.3

3.8

—

Viral warts

278

2.10

6.55

3.9

3.8

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

158

1015

1.55

6.52

3.5

4.1

—

Benign neoplasm of mouth and pharynx

388

1.92

6.52

4.4

3.8

—

Gangrene, not elsewhere classified

7.68

6.49

2.9

3.2

—

Other and specified injuries of hip and thigh

3.26

6.46

6.0

3.5

—

Diabetes, insulin treatment (Kela reimbursement)

568

2712

1.27

6.46

3.4

3.9

—

Acute myeloid leukaemia and myelodysplastic syndromes

3.45

6.46

3.8

3.5

—

Other and unspecified psoriasis

221

2.24

6.46

3.5

3.9

—

Barrett oesophagus

165

2.45

6.45

3.4

4.1

—

Mental and behavioural disorders due to cannabinoids

3.95

6.45

2.3

3.8

—

Other joint disorders

441

1774

1.31

6.44

3.5

4.0

—

Polyarthrosis

122

688

1.65

6.44

3.6

3.7

—

Acute pancreatitis

123

751

1.65

6.44

3.6

3.5

—

Sleep disorders, other/unspecified

3.32

6.43

4.9

4.0

—

Systemic lupus erythematosus, unspecified

3.01

6.41

2.4

3.5

—

Secondary uncertain malignant neoplasm

433

1.86

6.39

2.9

3.9

—

Dental operations

389

1498

1.34

6.39

3.7

—

Persistent mood disorders

103

601

1.72

6.39

4.2

3.7

—

Personal history of allergy to drugs, medicaments and biological substances

5.31

6.39

5.7

3.1

—

General examination and investigation of persons without complaint and reported diagnosis

303

1140

1.39

6.38

4.0

3.7

—

Tobacco use

148

2.53

6.36

2.7

4.5

—

Polymyalgia rheumatica

514

1.78

6.34

3.1

3.5

—

Disorder of external ear, unspecified

103

2.86

6.29

3.7

3.4

—

Peripheral artery operations in Hilmo

530

1.77

6.28

3.8

3.6

—

Diseases of tongue

155

2.47

6.27

3.7

4.0

—

Gonarthrosis [arthrosis of knee](FG)

420

1863

1.31

6.26

3.4

3.8

—

Collagenous colitis

297

2.04

6.24

4.4

3.8

—

Benign neoplasm: Ascending colon

539

1.76

6.23

3.7

—

Other disorders involving the immune mechanism, not elsewhere classified

2.95

6.18

4.3

4.5

—

Other skin changes

113

683

1.66

6.18

4.4

3.6

—

Congenital malformations, deformations and chromosomal abnormalities

298

2017

1.36

6.16

3.7

4.0

—

Injuries to the elbow and forearm

367

2443

1.32

6.16

4.1

3.9

—

Disorders of tooth development and eruption

322

1.89

6.15

4.8

4.0

—

Personal history of allergy to analgesic agent

8.97

6.13

5.0

2.7

—

Amputation of toe

293

2.04

6.11

3.9

3.5

—

Other disorders of bone

579

1.72

6.11

3.4

3.9

—

Cardiac murmurs and other cardiac sounds

143

2.50

6.11

4.8

4.0

—

Faecal incontinence

286

2.04

6.10

4.0

3.5

—

Arthropathies

454

1774

1.30

6.10

3.6

4.0

—

Fracture of foot, except ankle

119

731

1.63

6.10

4.0

—

Disorders of sclera, cornea, iris and ciliary body

291

2139

1.36

6.08

3.8

3.9

—

Urticaria

138

879

1.57

6.08

4.4

3.8

—

Seborrhoeic keratosis

143

920

1.56

6.06

4.0

3.6

—

Psoriasis

156

1023

1.53

6.05

3.3

3.8

—

Benign neoplasm of middle ear and respiratory system

294

2.03

6.05

5.0

3.9

—

Aortic aneurysm

159

1028

1.52

6.02

3.2

3.5

—

Tumor necrosis factor alpha inhibitors

413

1.85

6.02

3.8

4.1

—

Osteomyelitis

215

2.21

6.01

3.8

3.6

—

Use of donepezil

950

0.49

6.00

3.3

3.5

—

Fracture of skull and facial bones

114

696

1.64

5.99

4.0

3.9

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

144

501

1.59

5.99

3.3

3.9

—

Coxibs

165

564

1.55

5.98

3.7

4.5

—

Alcohol abuse, main dg, excluding more controls

421

1.84

5.98

4.0

3.9

—

Fibroblastic disorders

139

891

1.57

5.98

3.4

3.6

—

Diseases of pulp and periapical tissues and dental caries

398

1551

1.32

5.95

3.7

3.8

—

Other specified/unspecified hearing loss

324

1.96

5.92

3.6

3.3

—

Other local infections of skin and subcutaneous tissue

338

1.94

5.90

3.6

—

Psoriatic and enteropathic arthropathies

331

1.94

5.90

3.2

3.7

—

Sleep disorders

446

2512

1.28

5.89

3.6

4.0

—

Idiopathic gout

388

1.87

5.89

3.3

3.7

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.99

5.87

4.4

—

Other coagulation defects

211

2.20

5.85

3.1

3.6

—

ILD and respiratory illness in diseases classified elsewhere

7.26

5.84

2.7

4.1

—

Elevated blood glucose level

271

2.05

5.82

3.3

3.7

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

167

2.35

5.82

3.5

3.6

—

Exclusions for E4_PCOS_BROAD

520

1.74

5.81

4.0

3.9

—

Localized swelling, mass and lump of skin and subcutaneous tissue

171

1154

1.49

5.80

4.3

3.7

—

Hypokalaemia

397

1.85

5.79

3.4

3.8

—

Other diseases of pancreas

320

1.96

5.78

3.2

3.9

—

Malignant immunoproliferative diseases

4.04

5.78

5.0

4.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

353

2147

1.32

5.78

3.5

3.8

—

Other and unspecified local infections of skin and subcutaneous tissue

320

1.95

5.77

3.7

—

Other and unspecified injuries of head

232

2.13

5.76

3.6

4.3

—

Calcific aortic valvular stenosis, including rheumatic fever

204

1381

1.44

5.76

3.2

3.5

—

Other and unspecified disorders of vitreous body

241

1711

1.39

5.75

4.1

3.6

—

Carcinoma in situ of skin of upper limb, including shoulder

103

2.78

5.74

5.3

3.6

—

Disorders of choroid and retina

477

2674

1.27

5.73

3.8

3.7

—

Acute pancreatitis (for exclusion)

123

775

1.59

5.72

3.6

—

Paracetamol or NSAID medication

231

1.84

5.71

3.9

5.2

—

Operations 2 for CAVS

203

1377

1.44

5.70

3.2

3.5

—

Calcific aortic valvular stenosis, diagnosis (helper)

203

1377

1.44

5.70

3.2

3.5

—

Arterial embolism and thrombosis

220

2.16

5.69

2.6

3.2

—

Fibrosis and cirrhosis of liver

281

2.01

5.66

3.7

3.9

—

Inguinal or femoral hernia, bilateral

422

1.81

5.66

3.8

3.7

—

Viral and other specified intestinal infections

116

696

1.61

5.65

5.2

4.2

—

Hyperkalaemia

195

2.23

5.64

4.0

3.8

—

Calcific aortic valvular stenosis, operated

203

1380

1.43

5.64

3.2

3.5

—

Calcific aortic valvular stenosis

203

1380

1.43

5.64

3.2

3.5

—

Postmenopausal bleeding

148

508

1.56

5.64

3.7

3.8

—

Other bacterial agents as the cause of diseases classified to other chapters

5.17

5.63

8.5

4.0

—

Other and unspecified visual disturbances

330

1.92

5.62

3.2

3.9

—

Disorders of mineral metabolism

268

2.03

5.62

4.5

4.0

—

Rheumatism, unspecified

401

1.83

5.62

4.0

3.9

—

Mixed and other personality disorders

176

2.29

5.62

3.1

4.4

—

Respiratory conditions due to other external agents

2.99

5.61

3.0

3.8

—

Inguinal hernia, bilateral

416

1.82

5.61

3.8

3.7

—

Fall on and from stairs and steps

141

921

1.54

5.61

3.7

—

Scleritis and episcleritis

164

2.34

5.59

3.2

3.8

—

Malignant neoplasm of mesothelium and soft tissue

128

2.53

5.55

3.5

4.1

—

Specific personality disorders

100

603

1.66

5.55

3.4

4.2

—

7.50

5.54

2.8

3.8

—

Melanocytic naevi of trunk

375

1.85

5.51

3.4

3.9

—

Other (not insulin) diabetes medications

538

2559

1.25

5.49

3.3

3.8

—

Benign neoplasm: Tongue

100

2.75

5.46

4.1

3.7

—

Calculus of kidney and ureter

180

1245

1.45

5.42

3.3

3.6

—

Hypoplasia of dental enamel

16.26

5.42

13.7

2.8

—

Intestinal stricture

187

1303

1.44

5.42

3.6

—

Fissure and fistula of anal and rectal regions

127

818

1.56

5.39

4.0

3.8

—

Glomerular disorders in diseases classified elsewhere

437

1.77

5.35

4.5

3.4

—

Diffuse large B-cell lymphoma, including Hilmo

155

2.35

5.35

3.8

—

Diffuse large B-cell lymphoma

155

2.35

5.35

3.8

—

Diffuse large B-cell lymphoma, helper endpoint

155

2.35

5.35

3.8

—

Diseases of external ear

186

1298

1.44

5.35

3.6

3.7

—

Other hammer toe(s) (acquired)

104

589

1.64

5.34

3.7

3.8

—

Myelodysplastic syndrome, including Hilmo

107

2.66

5.34

3.5

3.1

—

Acute alcohol intoxication

143

948

1.51

5.33

3.5

3.7

—

Inguinal hernia

335

1703

1.32

5.33

3.7

—

Other congenital malformations, not elsewhere classified

9.34

5.32

10.6

2.7

—

Trigger finger

445

1.76

5.32

3.6

3.8

—

Amputation

394

1.81

5.32

3.8

3.4

—

Reactive arthropathies

267

2.00

5.31

4.5

4.1

—

Ventral hernia

134

877

1.53

5.31

3.8

3.5

—

Impetigo

2.80

5.31

6.6

3.7

—

Purpura and other haemorrhagic conditions

490

1.72

5.31

3.5

3.7

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

131

2.47

5.31

4.4

3.5

—

Hypertrophic cardiomyopathy

150

2.36

5.26

3.6

4.1

—

Phlebitis and thrombophlebitis (not including DVT)

124

800

1.56

5.25

3.7

3.6

—

Pleural plaque without asbestos

163

2.31

5.24

3.9

3.4

—

Mouth breathing

210

1502

1.40

5.23

3.4

3.8

—

Other specified and unspecified disorders of eye and adnexa

120

2.53

5.22

4.3

3.7

—

Biguanides

530

2603

1.24

5.22

3.1

3.9

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

347

1.86

5.18

3.2

3.7

—

Rare circulating lymphoid malignancy, including Hilmo

2.83

5.16

3.9

3.6

—

Molar incisor enamel hypoplasia, with caries

13.55

5.08

13.8

4.0

—

Nonsuppurative otitis media

525

1.64

5.08

4.3

4.5

—

Other metabolic disorders

349

1.84

5.08

3.6

4.0

—

Fracture of lower leg, including ankle

287

2146

1.33

5.08

3.3

3.9

—

Other maltreatment syndromes

2.93

5.05

4.3

3.8

—

Anosmia

3.78

5.04

3.1

4.0

—

Malignant neoplasm of bladder, including Hilmo

457

1.73

5.04

3.7

3.8

—

Coxarthrosis [arthrosis of hip](FG)

312

1671

1.32

5.00

3.6

3.7

—

Arthropathies in other diseases classified elsewhere

117

2.51

4.97

3.3

4.5

—

Episcleritis

129

2.42

4.97

3.3

3.8

—

Infection of intervertebral disc (pyogenic)

3.74

4.96

4.8

3.5

—

Adult respiratory distress syndrome

3.74

4.96

2.7

4.0

—

Acquired haemolytic anaemia

2.90

4.95

2.8

3.9

—

Abscess of anal and rectal regions

233

2.03

4.94

3.1

4.0

—

Allergic urticaria

213

2.08

4.93

3.9

3.5

—

Malignant neoplasm of bladder

247

2.00

4.92

3.9

3.6

—

Insomnia

423

2446

1.26

4.92

3.5

4.0

—

Superficial injury of wrist and hand

585

1.63

4.91

4.5

3.9

—

Other aneurysm

207

2.10

4.91

3.4

3.1

—

Right bundle-branch block

112

2.53

4.89

3.2

4.2

—

Insulin, fast-acting

191

1362

1.41

4.89

3.9

3.7

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

137

919

1.50

4.88

3.3

3.6

—

Unspecific neurodegenerative disorder

160

1567

0.70

4.86

3.5

3.6

—

Nephrotic syndrome

2.67

4.84

3.5

4.7

—

Pruritus

319

1.86

4.83

2.8

3.5

—

Adalimumab

242

1.99

4.83

3.8

4.2

—

Shigellosis

6.69

4.82

3.0

3.7

—

Myocardial infarction, without ST-elevation

264

1809

1.33

4.81

3.3

3.6

—

Other and unspecified diseases of blood and blood-forming organs

2.78

4.80

2.8

4.0

—

Other diseases of blood and blood-forming organs

243

1.99

4.79

3.3

3.7

—

Carcinoma in situ of skin of trunk

138

2.36

4.79

3.9

3.6

—

Arthrosis

381

1636

1.28

4.77

3.3

3.7

—

Acute suppurative otitis media

557

1.61

4.73

5.2

4.6

—

Use of other anti-dementia drugs

1178

0.62

4.73

3.2

3.5

—

Use of memantine

1178

0.62

4.73

3.2

3.5

—

Olecranon bursitis

217

2.05

4.72

4.1

—

Pneumoconiosis due to asbestos and other mineral fibres

2.75

4.71

3.4

3.3

—

Other diseases of arteries and capillaries

308

1.86

4.70

3.4

—

Alcohol withdrawal state with delirium

252

1.96

4.69

3.1

4.0

—

Psoriatic arthropathies

301

1.87

4.69

3.2

4.0

—

Propionic acid derivatives

165

569

1.46

4.67

3.4

4.7

—

Cardiac arrest

139

2.23

4.67

3.5

3.9

—

Cirrhosis of liver, NAS

198

2.09

4.66

4.0

—

Panic disorder

330

1.82

4.66

4.0

4.2

—

Open wound of forearm

302

1.87

4.64

3.1

3.6

—

Monoamine oxidase A inhibitors

360

1.79

4.63

3.3

3.8

—

Other sleep disorders

331

1.82

4.63

3.4

3.9

—

Adhesive capsulitis of shoulder

564

1.62

4.62

3.4

3.7

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

10.83

4.62

3.8

3.1

—

Mesothelioma

4.66

4.61

2.4

4.2

—

Other enthesopathies

146

1004

1.46

4.60

3.8

3.9

—

Other infective otitis externa

179

2.14

4.60

3.1

4.0

—

Meniscus derangement

299

1544

1.31

4.57

3.5

3.7

—

Injury of unspecified body region

262

1.92

4.54

4.1

3.9

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

4.89

4.51

5.9

5.3

—

Disorders of vitreous body

280

2073

1.31

4.51

4.1

3.6

—

Neuroendocrine tumor and carcinoma of lung

5.40

4.51

3.3

5.1

—

Acute laryngitis and tracheitis

217

2.00

4.50

4.7

3.7

—

Gonarthrosis

350

1558

1.28

4.50

3.3

3.7

—

Other arterial embolism and thrombosis

2.62

4.49

2.6

3.5

—

Foreign body in respiratory tract

136

2.30

4.46

3.1

4.2

—

Exposure to other and unspecified inanimate mechanical forces

222

2.00

4.45

4.2

—

Bacterial, viral and other infectious agents

271

1.89

4.44

6.2

4.2

—

Urolithiasis

190

1380

1.38

4.43

3.3

3.6

—

Acute bronchiolitis

2.73

4.41

8.0

4.3

—

Disorders of vitreous body and globe

287

2129

1.30

4.38

4.0

3.6

—

Other neurotic disorders

150

2.22

4.38

3.4

4.6

—

Personal history of other diseases and conditions

243

1.93

4.37

3.4

4.0

—

Anaemia in chronic diseases classified elsewhere

2.77

4.37

3.1

4.0

—

Small cell lung cancer

2.76

4.37

3.4

—

Small cell lung cancer, including Hilmo

2.76

4.37

3.4

—

Toxic liver disease

3.26

4.36

3.7

3.9

—

Charcot foot

3.25

4.36

2.7

3.7

—

Bacterial, viral and other infectious agents

259

1.90

4.34

5.6

4.2

—

Misadventures to patients during surgical and medical care

489

1.64

4.32

4.2

3.8

—

Other specified/unspecified dorsopathies

2.61

4.32

2.9

3.5

—

Benign neoplasm: Caecum

422

1.69

4.28

3.7

3.6

—

Mucosal proctocolitis

363

1.74

4.23

3.3

3.8

—

Other overlap syndromes

3.19

4.23

5.4

3.9

—

Mental disorders, not otherwise specified

192

2.04

4.23

3.6

4.1

—

Benign neoplasm: Adrenal gland

276

1.86

4.23

3.5

3.8

—

Diabetic neuropathy

444

1.67

4.22

3.0

3.5

—

Diplopia

454

1.66

4.22

4.0

3.6

—

Postmenopausal osteoporosis with pathological fracture

213

1.99

4.22

3.9

3.6

—

Pedestrian injured in transport accident

206

2.00

4.22

4.4

4.1

—

Inflammatory diseases of the central nervous system

269

1.87

4.21

4.2

3.7

—

Abnormal findings in nipple discharge synovial fluid wound secretions

3.32

4.21

5.4

4.1

—

Generalized anxiety disorder

334

1.77

4.21

4.8

4.6

—

Other/unspecified rheumatoid arthritis

447

1.66

4.20

4.0

3.6

—

Hernia of abdominal wall

252

1928

1.31

4.18

3.7

3.6

—

ILD medications: acetylcysteine

5.36

4.17

3.7

2.7

—

Contusion of toe(s) with damage to nail

5.35

4.17

3.6

3.5

—

Coxarthrosis

285

1453

1.30

4.16

3.5

3.7

—

Other/unspecified enthesopathies of lower limb, excluding foot

180

2.07

4.15

3.9

4.2

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

503

1.62

4.13

2.8

3.8

—

Bicipital tendinitis

154

2.16

4.13

2.9

4.3

—

Hypertensive Renal Disease

122

2.32

4.12

3.0

3.1

—

Selective deficiency of immunoglobulin A [IgA]y

8.35

4.11

4.5

3.0

—

Migraine with aura and triptan purchases

322

1.78

4.10

5.4

4.3

—

Molar incisor enamel hypoplasia

4.35

4.09

10.1

4.5

—

Blepharochalasis

165

1189

1.39

4.08

3.4

3.7

—

Hallux valgus (acquired)

167

860

1.40

4.07

3.1

3.8

—

Vascular diseases of the intestine

142

2.21

4.06

3.2

3.4

—

Pleural plaque with presence of asbestos

324

1.77

4.05

3.4

—

Hypermobility syndrome

2.57

4.05

3.6

3.4

—

Disorders of plasma-protein metabolism, not elsewhere classified

5.17

4.05

2.6

3.0

—

Intestinal malabsorption

136

2.23

4.03

7.3

4.3

—

Malignant neoplasm of heart, mediastinum and pleura

3.97

4.02

2.1

3.9

—

Mixed conductive and sensorineural hearing loss

468

1.63

4.02

3.4

—

Other peripheral vascular diseases

252

1.88

4.02

3.4

—

Systemic sclerosis (FG)

2.70

4.01

4.1

3.5

—

Other/unspecified enthesopathies, not elsewhere classified

281

1.83

4.01

3.6

3.9

—

Symptoms and signs involving emotional state

2.69

4.00

7.2

4.0

—

Inflammatory bowel disease

149

1059

1.41

3.99

3.4

3.8

—

Other mycoses, not elsewhere classified/unspecified

3.07

3.99

4.1

3.8

—

Insulin, fast-acting or short human

192

1422

1.35

3.99

3.9

3.7

—

Helminthiases

2.55

3.97

2.6

3.7

—

Attention to artificial openings

137

2.21

3.97

3.7

3.9

—

Suppurative and unspecified otitis media

140

871

1.43

3.95

4.7

4.3

—

Multiple myeloma and malignant plasma cell neoplasms

191

2.01

3.94

2.8

3.8

—

Disorders of muscles

305

1.78

3.92

4.2

3.8

—

Oesophageal varices

151

2.14

3.91

6.1

4.0

—

Emotionally unstable personality disorder

233

1.90

3.90

3.1

4.3

—

Other hearing loss

177

1272

1.37

3.90

3.3

3.5

—

Valvular operations

480

1.61

3.88

3.6

3.7

—

Other/unspecified synovitis and tenosynovitis

343

1.73

3.88

3.6

3.9

—

Myocardial infarction, with ST-elevation

115

784

1.47

3.88

3.4

3.5

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

4.43

3.86

5.8

3.9

—

Migraine without aura

396

1.67

3.86

3.4

4.5

—

Neuromuscular dysfunction of bladder

292

1.79

3.86

3.8

3.7

—

Cerebral palsy and other paralytic syndromes

359

1.71

3.84

3.7

—

Event of undetermined intent

179

2.02

3.84

4.5

4.0

—

Disorders of calcium metabolism

193

1.98

3.82

3.0

4.2

—

Hypoplasia of dental enamel , including avohilmo

4.34

3.82

10.7

4.0

—

Post-traumatic wound infection, not elsewhere classified

2.63

3.82

5.7

4.2

—

Scoliosis

207

1.94

3.81

3.8

4.2

—

Keratitis

174

1280

1.36

3.81

4.4

3.7

—

Disorders of parathyroid gland

118

802

1.46

3.79

3.6

—

Palmar fascial fibromatosis [Dupuytren]

634

1.52

3.78

3.5

3.6

—

Extrapyramidal and movement disorders

216

1643

1.32

3.78

4.1

3.6

—

Diseases of spleen

2.78

3.78

2.4

3.6

—

Exclusions for E4_PCOS_CONSORTIUM

313

1551

1.27

3.77

3.9

—

Exposure to other and unspecified animate mechanical forces

2.75

3.76

4.8

4.0

—

Pacemaker

208

1509

1.32

3.75

3.4

3.5

—

Hypersensitivity pneumonitis due to organic dust

2.84

3.71

4.7

4.1

—

Diabetic nephropathy, excluding more controls

410

1.59

3.71

2.8

3.5

—

Other superficial mycoses

2.82

3.70

3.2

3.6

—

Metatarsalgia

252

1.83

3.70

3.4

4.1

—

Other disorders of conjunctiva

510

1.58

3.70

3.8

3.7

—

Dialysis

122

2.23

3.68

3.9

4.4

—

Traumatic subarachnoid haemorrhage

122

2.23

3.68

3.3

4.2

—

Disorders of orbit

122

2.23

3.68

2.9

3.4

—

Malignant neoplasm of oral cavity, including Hilmo

135

2.17

3.68

2.5

4.2

—

Viral agents as the cause of diseases classified to other chapters

2.72

3.67

4.7

3.9

—

Other congenital malformations

196

1.95

3.66

6.3

4.5

—

Corticotropin deficiency

4.52

3.66

6.8

3.8

—

Alzheimer disease, including avohilmo

141

1376

0.72

3.65

3.2

3.6

—

Artrosis, including avohilmo

446

2011

1.22

3.65

3.4

3.8

—

Cluster headache, strict

2.62

3.64

3.2

4.5

—

Acute gastritis

261

1.81

3.64

3.4

3.7

—

Mesothelioma, including Hilmo

3.57

3.63

2.4

3.9

—

Chalazion

350

1.69

3.63

3.4

3.9

—

Insulin, intermediate and long-acting

306

2376

1.25

3.63

3.3

3.7

—

Spondyloarthritis

584

1.53

3.62

3.6

—

Obesity due to excess calories

207

1576

1.32

3.62

3.3

3.9

—

Umbilical hernia

139

997

1.40

3.58

3.4

3.7

—

Open wound of ankle and foot

329

1.71

3.58

4.0

3.8

—

Systemic sclerosis

2.53

3.56

4.1

3.3

—

Epilepsy

152

1104

1.38

3.56

3.4

3.9

—

Hypersensitivity angiitis

5.51

3.56

4.2

3.6

—

Diseases of middle ear and mastoid

249

1588

1.28

3.55

4.4

3.9

—

Schizophrenia or delusion, excluding more controls

124

865

1.42

3.53

3.4

4.1

—

Assault by bodily force

178

1.98

3.53

4.6

3.9

—

Cholelithiasis, broad definition with cholecystitis

465

2607

1.20

3.52

3.4

3.7

—

Allergic contact dermatitis

361

1.67

3.51

4.9

3.8

—

Amiodarone users

431

1.61

3.51

3.3

3.6

—

Enthesopathies of lower limb, excluding foot

103

703

1.47

3.49

4.0

3.8

—

Cervicobrachial syndrome

672

1.48

3.45

3.3

3.8

—

Etanercept

166

2.00

3.44

3.8

3.6

—

Failure and rejection of transplanted organs and tissues

3.04

3.44

4.9

4.0

—

Abnormal spermatozoa

543

0.49

3.43

3.1

3.6

—

Excessive, frequent and irregular menstruation

151

597

1.39

3.42

4.2

4.0

—

Multiple myeloma

2.42

3.41

2.7

3.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

2.42

3.41

2.7

3.3

—

Systemic sclerosis, icd10

2.47

3.40

4.1

3.4

—

Other obstetric conditions, not elsewhere classified

281

1.61

3.38

3.4

4.4

—

Fracture of shoulder and upper arm

187

1417

1.32

3.38

3.8

—

Superficial injury of hip and thigh

554

1.52

3.37

3.0

3.6

—

Alcohol-induced acute pancreatitis

127

2.15

3.37

3.5

4.8

—

Atypical facial pain

147

2.06

3.36

3.9

3.6

—

Otitis externa, unspecified

320

1.70

3.36

3.3

4.0

—

Other and/or unspecified nontoxic goitre

268

1.76

3.36

3.2

3.7

—

Arthropathic psoriasis

366

1.65

3.36

3.2

3.8

—

Other and unspecified nonorganic psychotic disorders

507

1.54

3.34

3.3

4.2

—

Superficial injury of ankle and foot

313

1.70

3.34

4.3

4.4

—

Other benign neoplasms of skin

200

1535

1.31

3.34

4.0

3.7

—

Other (seronegative) rheumatoid arthritis, wide

102

702

1.46

3.33

3.8

3.6

—

Polyarthritis, unspecified

108

2.24

3.33

3.4

4.6

—

Viral and other specified intestinal infections

503

1.54

3.32

5.1

4.2

—

Diseases of male genital organs

297

1194

1.26

3.31

4.0

3.8

—

Other renal tubulo-interstitial diseases

2.64

3.31

8.2

3.6

—

Alcohol abuse, main dg

501

1.54

3.30

4.0

3.6

—

Other and unspecified urticaria

565

1.51

3.30

3.8

4.0

—

Abnormal blood-pressure reading, without diagnosis

2.48

3.30

3.1

3.0

—

Diseases of the myoneural junction and muscle

478

1.56

3.28

3.0

3.7

—

Inflammatory diseases of female pelvic organs

237

1363

1.28

3.27

4.0

3.9

—

Polycystic ovarian syndrome, consortium definition

281

1325

1.26

3.26

4.2

3.8

—

Hordeolum and other deep inflammation of eyelid

156

2.00

3.25

5.5

4.2

—

Chronic diseases of tonsils and adenoids

312

1591

1.24

3.24

3.6

3.8

—

Malignant neoplasm of larynx, including Hilmo

2.70

3.24

7.6

4.7

—

Other follicular disorders

191

1.90

3.24

3.5

4.3

—

Scar conditions and fibrosis of skin

103

2.25

3.23

3.4

3.5

—

Pyoderma gangrenosum

4.28

3.22

2.4

3.7

—

Ulcerative colitis

113

798

1.42

3.22

3.5

3.8

—

Open wound of abdomen, lower back and pelvis

2.46

3.22

2.8

4.0

—

Tinnitus

118

841

1.41

3.20

4.6

3.5

—

Other retinal disorders

367

2359

1.21

3.19

3.7

—

Osteonecrosis due to drugs

2.78

3.18

3.5

4.2

—

Cardiomyopathy, Hypertrophic obstructive

2.76

3.17

3.9

3.7

—

Disorders of continuity of bone

273

1.73

3.17

4.9

4.1

—

Muscle strain

2.37

3.16

5.0

3.8

—

Use of rivastigmine

705

0.58

3.15

3.3

3.5

—

Urethral stricture

222

1.82

3.15

2.9

3.6

—

IgA nephropathy (IgA glomerulonephritis)

2.50

3.14

5.0

3.5

—

Viral agents as the cause of diseases classified to other chapters

2.49

3.14

4.7

3.8

—

Other disorders of the genitourinary system

420

1.58

3.14

3.2

3.5

—

Other enthesopathy of foot (+metatarsalgia)

274

1.72

3.13

3.4

4.1

—

Other diseases of stomach and duodenum

223

1.81

3.11

3.7

3.9

—

Hepatomegaly and splenomegaly, not elsewhere classified

4.08

3.10

4.7

3.6

—

Other mycoses, not elsewhere classified/unspecified

5.25

3.10

5.0

4.9

—

Delirium, not induced by alcohol and other psychoactive substances

524

1.51

3.10

3.2

3.6

—

Haemorrhoids and perianal venous thrombosis

166

1253

1.32

3.10

3.3

3.7

—

Symptoms and signs involving the nervous and musculoskeletal systems

300

2440

1.23

3.10

3.5

3.8

—

Benign neoplasm of breast

328

1.65

3.10

4.0

3.6

—

Anogenital herpesviral [herpes simplex] infection

223

1.80

3.10

4.0

4.3

—

Colonic or urogenital fistula

134

982

1.37

3.09

3.9

3.6

—

Malignant neoplasm of thymus

7.81

3.09

2.7

3.0

—

Other keratitis

336

1.64

3.09

4.7

3.7

—

Mantle cell lymphoma, including Hilmo

3.23

3.07

3.2

4.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

305

1.64

3.06

3.2

5.5

—

Other and unspecified glaucoma

299

1.68

3.06

3.8

3.9

—

Dermatitis due to substances taken internally

160

1.95

3.04

7.6

3.4

—

Abnormal involuntary movements

471

1.54

3.04

4.0

3.7

—

Idiopathic thrombocytopenic purpura

2.28

3.04

4.7

3.9

—

Thyrotoxicosis

118

850

1.39

3.03

3.9

3.8

—

Oesophageal obstruction

133

2.05

3.02

4.4

4.1

—

Macular pucker

651

1.45

3.02

3.7

3.4

—

Disorders of refraction and accommodation

109

772

1.41

3.01

4.0

3.9

—

Golimumab

2.32

3.01

4.5

3.9

—

Oxicams

128

524

1.39

3.00

3.4

4.1

—

Injury of other and unspecified intrathoracic organs

233

1.77

3.00

3.2

3.8

—

Drug-induced cataract

2.38

3.00

3.3

3.9

—

Acute myeloid leukaemia

3.92

3.00

4.6

—

Acute myeloid leukaemia, helper endpoint

3.92

3.00

4.6

—

Acute myeloid leukaemia, including Hilmo

3.92

3.00

4.6

—

Nonalcoholic fatty liver disease

293

1.68

2.99

3.1

4.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

158

1194

1.33

2.99

4.1

3.8

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

139

1031

1.35

2.98

3.4

3.9

—

Other congenital malformations

316

1.65

2.98

5.4

4.5

—

Myeloid leukaemia

2.26

2.98

4.2

4.0

—

Morphin

2.57

2.97

6.0

3.2

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1091

0.69

2.97

3.4

3.9

—

Anogenital herpesviral [herpes simplex] infection

127

2.06

2.97

4.9

4.1

—

Coronary artery bypass grafting

155

867

1.34

2.96

3.2

3.5

—

Generalized skin eruption due to drugs and medicaments

114

2.12

2.95

8.7

3.6

—

Myeloproliferative diseases

310

1.66

2.94

3.6

3.7

—

Dementia, including avohilmo

194

1707

0.78

2.94

3.4

3.6

—

Panniculitis affecting regions of neck and back

2.29

2.94

3.6

3.7

—

Cluster headache, wide

2.29

2.94

3.2

4.5

—

Dementia

181

1606

0.77

2.92

3.3

3.6

—

Carcinoma in situ of skin of ear and external auricular canal

2.74

2.91

3.1

3.9

—

Open wound of wrist and hand

207

1591

1.27

2.90

4.1

3.9

—

Fracture of forearm

262

1938

1.24

2.90

4.2

3.9

—

Moderate visual impairment, monocular

5.58

2.90

8.9

2.8

—

Malignant neoplasm of head and neck

273

1.69

2.90

5.1

3.8

—

Acute lymphadenitis

142

1.98

2.90

4.0

3.7

—

Thoracic aortic aneurysm

558

1.48

2.90

3.4

3.5

—

Psoriasis vulgaris

640

1.44

2.89

3.3

3.6

—

Malignant neoplasm of thymus, including Hilmo

6.88

2.89

2.7

4.3

—

Enterobiasis

3.74

2.88

2.9

4.3

—

Other and unspecified disorders of adult personality and behaviour

6.81

2.88

2.8

2.1

—

Traumatic subdural haemorrhage

504

1.49

2.88

3.1

3.5

—

Entropion and trichiasis of eyelid

343

1.61

2.88

3.4

—

Somnolence, stupor and coma

122

2.06

2.87

5.4

4.5

—

Extreme obesity with alveolar hypoventilation

129

2.03

2.87

3.8

4.1

—

Status post-ami

153

879

1.33

2.86

3.1

3.5

—

Acute generalized exanthematous pustulosis

129

2.03

2.86

8.2

3.5

—

Effects of foreign body entering through natural orifice

115

834

1.38

2.86

3.3

3.8

—

KRA_PSY_EATING, excluding more controls

2.21

2.86

3.1

5.1

—

Hydronephrosis

407

1.55

2.84

3.7

3.3

—

Other psoriatic arthropathies

337

1.61

2.82

3.2

3.9

—

Spondylolisthesis/Spondylolysis

586

1.45

2.81

4.3

3.8

—

Malignant neoplasm of other connective and soft tissue

2.42

2.81

4.5

3.7

—

Chondropathies

464

1.51

2.81

3.6

3.9

—

Varicella [chickenpox]

123

2.04

2.81

2.9

3.9

—

Alzheimer’s disease (Atypical or mixed)

475

0.52

2.80

3.8

3.6

—

Diphtheria

8.97

2.80

2.6

3.2

—

Abnormal findings on diagnostic imaging of central nervous system

2.23

2.80

3.4

3.8

—

Erectile dysfunction

338

1.61

2.80

3.2

3.6

—

Diphtheria

8.88

2.79

2.6

3.2

—

Myelodysplastic syndrome

3.14

2.79

3.1

3.4

—

Small cell lung cancer, helper endpoint

2.19

2.78

3.4

3.6

—

Thrombocytopenia, unspecified

254

1.70

2.78

3.7

—

Diabetic maculopathy

449

0.52

2.76

3.8

3.4

—

Degeneration of macula and posterior pole

291

1899

1.22

2.76

3.5

3.6

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

271

1.55

2.75

3.5

4.5

—

L04AC Interleukin inhibitors

152

1.92

2.75

4.0

3.9

—

Pedestrian injured in collision with pedal cycle

2.22

2.74

4.4

4.0

—

Acquired absence of organs, not elsewhere classified

2.76

2.74

2.9

3.7

—

Other congenital malformations of integument

6.27

2.73

3.5

3.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

233

1.73

2.72

2.9

3.2

—

Personal history of medical treatment

3.06

2.72

3.8

3.6

—

Achalasia of cardia

2.63

2.71

2.6

4.6

—

Hypopituitarism

196

1.79

2.71

4.0

3.8

—

Vitamin deficiency, wide

146

1.93

2.70

4.2

3.8

—

Vitamin deficiency

146

1.93

2.70

4.3

3.8

—

Thrombotic microangiopathy

4.32

2.70

7.9

3.7

—

Other and unspecified mood [affective] disorders

146

1.93

2.70

5.3

4.1

—

Osteopathy in diseases classified elsewhere

3.84

2.70

2.6

4.3

—

Abdominal aortic aneurysm (AAA)

457

1.50

2.69

3.0

3.2

—

Iron deficiency anaemia secondary to blood loss (chronic)

609

1.43

2.68

3.3

3.6

—

Maternal care for other conditions predominantly related to pregnancy

350

1.57

2.68

3.2

4.1

—

Fall involving bed

119

2.04

2.67

3.5

3.7

—

Nail disorders

257

1.68

2.67

5.2

3.9

—

Panniculitis, unspecified

3.20

2.66

2.7

—

Malignant neoplasm of larynx

2.83

2.66

8.7

3.5

—

Cholelithiasis

438

2575

1.17

2.66

3.3

3.7

—

Iridocyclitis

105

761

1.38

2.65

3.0

3.6

—

2.13

2.64

4.0

4.9

—

Acute alcohol intoxication, ICD10

686

1.40

2.64

3.7

3.8

—

Eosinophilia

2.58

2.63

4.4

3.7

—

Premature rupture of membranes

290

0.49

2.62

2.6

4.3

—

Other and unspecified follicular disorders

113

2.05

2.62

3.6

3.8

—

Drug-induced Cushing's syndrome

7.83

2.61

2.6

3.4

—

Orthopaedic devices associated with adverse incidents

0.00

2.61

0.0

3.8

—

Diabetic retinopathy, strict definition

614

0.62

2.61

3.0

3.5

—

Other obstructive and reflux uropathy

120

2.01

2.61

3.3

3.5

—

Haemophagocytic lymphohistiocytosis

7.78

2.61

5.0

3.7

—

Disorders in reading

4.70

2.60

3.1

4.0

—

Drug-induced systemic lupus erythematosus

4.10

2.59

2.9

3.9

—

Disorder of mineral metabolism, other/unspecified

7.51

2.58

5.4

2.9

—

Rheumatic fever incl heart disease

107

2.07

2.58

3.8

3.9

—

Congenital malformations of lung

7.47

2.58

4.0

3.4

—

Myeloproliferative diseases (CML excluded)

283

1.64

2.58

3.7

—

Congenital malformations of lung

7.42

2.57

4.0

3.4

—

Nonischemic cardiomyopathy

361

1.56

2.57

3.8

—

Other or unspecified common variable immunodeficiency

7.38

2.57

7.2

3.1

—

Injury of muscle and tendon at shoulder and upper arm level

189

1497

1.27

2.57

3.5

3.6

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

5.63

2.57

3.7

5.8

—

Benign neoplasm of meninges

346

1.57

2.56

2.9

3.8

—

!Aliquae complicationes praecoces traumatis

142

1.92

2.56

5.3

3.7

—

Early complications of trauma

142

1.92

2.56

5.3

3.7

—

Other specified/unspecified soft tissue disorders

142

1.91

2.56

2.7

3.4

—

Caries of enamel

404

2480

1.18

2.55

4.2

3.9

—

Eating disorders

185

1.79

2.55

3.9

4.2

—

Thyroiditis, ILD-related definition

307

1.60

2.55

3.9

4.0

—

conjunctival haemorrhage

284

1.63

2.54

4.1

3.9

—

Sequelae of cerebrovascular disease

208

1436

1.25

2.54

3.3

3.5

—

Meralgia paraesthetica

101

2.10

2.53

3.0

3.9

—

Psoriatic arthropathies, ICD10

347

1.56

2.53

3.2

3.8

—

Bitten or struck by other mammals

300

1.61

2.52

4.1

4.2

—

Gingival hyperplasia

108

2.05

2.52

3.5

3.8

—

L01XX Other antineoplastic agents

225

1.70

2.47

2.6

3.9

—

Tongue abnormality

210

1.73

2.47

3.8

3.7

—

Essential (haemorrhagic) thrombocythaemia

123

1.97

2.46

4.4

4.1

—

Other and unspecified iridocyclitis

130

1.94

2.46

2.8

4.1

—

Nontoxic goitre/thyroid nodule

146

1127

1.30

2.45

3.2

3.7

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.20

2.42

3.1

4.6

—

Fatigue fracture of vertebra

5.13

2.42

3.3

3.7

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.19

2.41

4.4

3.4

—

Ovarian cyst

135

589

1.32

2.41

3.8

4.0

—

Sequelae of injuries of upper limb

304

1.59

2.41

3.6

4.0

—

Melanocytic naevi of lower limb, including hip

124

1.95

2.41

6.0

3.7

—

Type 1 diabetes

107

791

1.35

2.40

3.5

4.0

—

Use of galantamine

362

0.49

2.40

5.0

3.5

—

Immunodeficiency associated with other major defects

6.51

2.40

4.2

2.6

—

Toxic effects of substances chiefly nonmedicinal as to source

336

1.55

2.39

3.5

4.0

—

Persons encountering health services in other circumstances

166

1300

1.27

2.39

3.7

—

Malignant neoplasm of digestive organs

193

1217

1.25

2.39

3.9

3.7

—

Rheumatoid lung disease

4.26

2.39

3.9

3.5

—

Ulcer of oesophagus

266

1.63

2.38

3.4

3.6

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

167

846

1.28

2.38

3.9

3.8

—

Malignant neoplasm of breast, including Hilmo

167

846

1.28

2.38

3.9

3.8

—

Otalgia

220

1.69

2.37

4.4

3.5

—

Personal history of risk-factors, not elsewhere classified

3.07

2.36

3.6

3.8

—

Benign neoplasm of ovary

541

1.43

2.36

3.4

3.6

—

Mixed disorders of conduct and emotions, excluding more controls

4.14

2.36

7.0

3.4

—

Benign neoplasm of other and unspecified endocrine glands

467

1.46

2.36

3.6

3.8

—

Other and unspecified aplastic anaemias

2.87

2.36

3.3

3.9

—

Conductive and sensorineural hearing loss

434

2523

1.16

2.36

4.2

3.6

—

Erosion of teeth , including avohilmo

718

1.37

2.36

4.4

4.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

194

1545

1.25

2.35

4.0

3.8

—

Dissocial personality disorder

2.85

2.35

3.5

3.9

—

Respiratory and cardiovascular disorders specific to the perinatal period

4.19

2.35

7.1

7.9

—

Microscopic polyangiitis

3.31

2.33

6.8

3.1

—

Alcoholic liver disease

387

1.51

2.32

2.9

3.7

—

Alzheimer disease

130

1236

0.77

2.32

3.3

3.5

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

3.27

2.32

3.6

4.5

—

Other disorders of glucose regulation and pancreatic internal secretion

276

1.60

2.31

3.4

3.8

—

Other noninfective disorders of lymphatic vessels and lymph nodes

112

1.98

2.31

3.1

3.6

—

Postzoster neuralgia

2.41

2.31

4.1

3.9

—

Corneal scars and opacities

2.14

2.29

3.1

4.1

—

Unspecified transport accident

4.74

2.29

3.5

3.0

—

Spontaneous abortion

892

0.74

2.28

4.2

3.9

—

Amputation of foot

2.09

2.28

3.8

3.4

—

Paranoid personality disorder

2.58

2.28

4.8

4.4

—

Malignant neoplasm of breast

164

841

1.27

2.27

3.7

—

Migraine without aura and triptan purchases

325

1.54

2.26

3.5

4.2

—

Familial hypercholesterolemia

597

1.40

2.25

3.6

3.7

—

Short stature, not elsewhere classified

4.65

2.25

10.8

10.3

—

Other disorders starting during childhood or adolecense, excluding more controls

2.56

2.25

4.3

5.4

—

Other predominantly sexually transmitted diseases, not elsewhere classified

447

1.46

2.25

3.6

4.4

—

Other predominantly sexually transmitted diseases, not elsewhere classified

382

1.50

2.24

3.7

4.3

—

Crushed, pushed or stepped on by crowd or human stampede

186

1.73

2.24

5.0

4.3

—

Small plaque parapsoriasis

5.78

2.24

7.8

2.7

—

Ganglion

623

1.38

2.23

4.0

3.9

—

Uterine polyps

272

0.44

2.23

4.2

—

Injury of blood vessels at hip and thigh level

5.75

2.23

2.8

—

Disseminated intravascular coagulation [defibrination syndrome]

5.75

2.23

2.6

4.0

—

Chronic conjunctivitis

2.11

2.23

3.9

3.8

—

Torticollis

3.13

2.23

2.7

4.7

—

Thalassaemia

5.71

2.23

4.2

3.0

—

Corneal ulcer

590

1.39

2.22

4.8

3.8

—

Disorders of eyelid in diseases classified elsewhere

2.06

2.22

4.1

3.7

—

Carcinoma in situ of skin of scalp and neck

114

1.95

2.22

5.0

3.5

—

Malignant neoplasm of oesophagus, including Hilmo

121

1.92

2.21

4.8

4.1

—

Toxic effect of ethanol

107

1.97

2.20

4.6

3.9

—

Hyperkinetic disorders, excluding more controls

143

1.81

2.20

2.4

5.5

—

Hemiplegia

150

1.81

2.20

3.4

4.1

—

Lichen simplex chronicus and prurigo

210

1.68

2.20

3.3

3.8

—

Pediculosis, acariasis and other infestations

442

1.45

2.18

4.3

4.1

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

129

1.87

2.17

4.9

4.2

—

Anti-inflammatory and antirheumatic products, non-steroids

146

569

1.29

2.17

3.4

4.7

—

Normal-pressure hydrocephalus

197

0.40

2.17

2.6

3.8

—

Left bundle-branch block

234

1.63

2.16

3.3

3.8

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

353

1.51

2.16

2.9

3.9

—

Other and unspecified myopathies

337

1.52

2.16

3.0

3.9

—

Mantle cell lymphoma

3.06

2.16

2.7

4.1

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

211

1.66

2.16

3.3

4.2

—

Exophthalmic conditions

3.04

2.16

4.1

4.9

—

Melanoma in situ

181

1.73

2.16

3.0

3.5

—

Varicella [chickenpox]

115

1.92

2.15

3.0

3.9

—

Inflammatory disease of uterus

297

1.55

2.15

3.5

4.2

—

Cysts of oral region, not elsewhere classified

181

1.72

2.15

3.8

4.1

—

Assault by sharp object

2.65

2.15

4.6

4.0

—

Long labour

419

0.59

2.14

4.1

4.2

—

Bulimia nervosa (incl. atypical)

2.79

2.14

3.0

3.5

—

Malignant neoplasm of kidney, except renal pelvis

298

1.55

2.13

3.0

3.8

—

Thyrotoxicosis, other and/or unspecified

646

1.37

2.13

3.8

4.0

—

Chronic tubulo-interstitial nephritis

130

1.86

2.12

2.4

3.3

—

D07AA Corticosteroids, weak (group I)

411

1.46

2.12

4.0

4.3

—

Postprocedural musculoskeletal disorders, not elsewhere classified

267

1.58

2.12

3.2

3.8

—

Other bursopathies

445

1.44

2.12

3.3

3.7

—

Dronedarone medication

2.02

2.11

3.4

4.5

—

Other salmonella infections

116

1.91

2.11

3.4

—

Malignant neoplasm of urinary organs

331

1.52

2.11

3.1

3.8

—

Other infective spondylopathies

5.26

2.10

2.6

4.2

—

Injuries to the neck

699

1.35

2.10

4.1

3.7

—

Cholecystitis

563

1.39

2.10

3.4

3.7

—

Anorexia (incl.atypical)

109

1.93

2.10

4.4

4.5

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.60

2.09

3.1

3.7

—

Syphilis

2.15

2.09

2.9

4.2

—

Syphilis

2.15

2.09

2.9

4.2

—

Behavioural disorders, excluding more controls

3.21

2.09

3.5

4.8

—

Malignant neoplasm of breast, HER2-negative

161

837

1.26

2.08

3.7

—

Postviral fatigue syndrome

5.06

2.08

3.8

3.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

316

1.52

2.07

3.9

4.0

—

Lichen planus

447

1.44

2.07

3.5

3.9

—

Other encephalitis

2.09

2.07

3.8

3.7

—

Asymptomatic human immunodeficiency virus [HIV] infection status

3.58

2.07

4.1

3.9

—

Nail dystrophy

3.58

2.07

2.6

4.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

658

1.36

2.07

4.2

4.0

—

Explicit fungal Sepsis

3.57

2.07

5.4

3.8

—

Restless leg syndrome

439

1.44

2.07

4.5

3.8

—

Disorders of the thyroid gland

475

2711

1.14

2.07

3.4

3.8

—

Retinal vascular occlusion

506

1.41

2.06

3.4

3.5

—

Superficial injury of abdomen, lower back and pelvis

489

1.41

2.06

3.4

4.0

—

Systemic disorders of connective tissue in diseases classified elsewhere

4.12

2.06

3.8

3.2

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

4.10

2.05

4.5

3.5

—

Injuries involving multiple body regions

103

1.95

2.05

7.2

3.6

—

Other congenital malformations of urinary system

4.09

2.05

2.0

3.4

—

Male infertility

103

1.95

2.05

7.0

4.0

—

Dissociative [conversion] disorders

2.18

2.04

3.7

—

Monoplegia

2.43

2.03

4.0

3.9

—

Glaucoma suspect

125

1595

0.78

2.03

3.2

3.6

—

Malignant neoplasm of testis, including Hilmo

2.42

2.03

3.2

3.8

—

Pregnancy hypertension

963

0.73

2.03

3.5

4.0

—

Other disorders of penis

334

1.50

2.03

4.4

3.5

—

Varicose veins

322

2079

1.17

2.02

3.4

3.7

—

Ascites

231

1.61

2.02

3.1

4.0

—

Cushing syndrome

2.67

2.01

2.4

4.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

116

1.87

2.01

2.6

3.9

—

Abnormal findings on examination of urine, without diagnosis

140

1.80

2.01

4.4

4.3

—

Encephalitis

2.02

2.01

5.2

3.8

—

Toxic effect of other and unspecified substances

2.84

2.01

3.2

4.0

—

Other abnormalities of plasma proteins

2.31

1.99

5.9

3.7

—

Marginal zone B-cell lymphoma, including Hilmo

2.31

1.99

2.6

5.2

—

Juvenile osteochondrosis

2.16

1.98

3.7

3.9

—

Speech and linguistic disorders, excluding more controls

132

1.79

1.97

2.9

5.6

—

Primary open-angle glaucoma

121

1492

0.78

1.97

3.6

—

Dislocation, sprain and strain of joints and ligaments of knee

248

1920

1.19

1.97

3.6

4.0

—

Degenerative diseases of the nervous system

149

1366

0.80

1.97

3.3

3.5

—

Acute nasopharyngitis (common cold)

318

1.50

1.97

3.1

3.4

—

Intestinal helminthiases, other/unspecified

4.72

1.96

2.6

3.3

—

Malignant neoplasm of oesophagus

2.04

1.96

5.8

4.6

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

4.67

1.96

3.2

4.4

—

Progressive systemic sclerosis

3.85

1.95

5.8

4.6

—

Collapsed vertebra, not elsewhere classified

3.02

1.95

4.1

—

Heartburn

313

1.51

1.95

5.1

3.9

—

Other injuries of lower limb, level unspecified

3.01

1.95

3.3

3.1

—

Previous suicide attempt

3.00

1.94

3.8

3.5

—

Blepharospasm

2.77

1.94

6.8

3.6

—

Paralytic ileus

127

1.82

1.94

2.8

4.0

—

Peritonsillar abscess

512

1.39

1.94

3.3

3.9

—

Galactorrhea

3.79

1.94

3.2

3.8

—

Superficial injuries involving multiple body regions

2.13

1.93

5.8

3.8

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

104

797

1.31

1.92

3.8

3.6

—

Plantar fascial fibromatosis

282

1.53

1.92

2.9

4.0

—

Benign neoplasm: Liver

2.26

1.91

2.6

4.1

—

Benign neoplasm: Other and unspecified parts of mouth

106

1.90

1.91

6.0

3.7

—

Pre-eclampsia

460

0.61

1.91

3.5

4.0

—

Sequelae of other and unspecified infectious and parasitic diseases

150

1.74

1.91

5.1

4.1

—

Other and unspecified mononeuropathies, also in other diseases

1.97

1.90

4.3

3.8

—

Childhood allergy (age < 16)

141

1.70

1.90

4.9

7.5

—

Cyst of kidney

275

1.54

1.89

3.9

3.7

—

Superficial injury of shoulder and upper arm

381

1.45

1.89

3.6

3.8

—

malignant neoplasm of male genital organs

154

751

1.25

1.88

3.1

3.8

—

Conotruncal defects

3.21

1.88

5.7

3.2

—

Other and unspecified acquired haemolytic anaemias

2.69

1.88

2.9

3.6

—

Disorder of pancreatic internal secretion, other and/or unspecified

2.91

1.88

4.4

4.1

—

Benign neoplasm: Stomach

357

1.46

1.87

3.4

3.8

—

Excessive attrition of teeth

235

1978

1.19

1.87

4.2

3.9

—

Malignant melanoma

499

1.39

1.87

3.2

3.8

—

Unspecified dementia

488

0.64

1.86

2.6

3.5

—

Other shoulder lesions

276

1.53

1.86

3.6

4.0

—

Recurrent dislocation and subluxation of joint

174

1.67

1.86

3.4

4.3

—

Perforation of oesophagus

3.61

1.85

3.8

4.9

—

Disorders of purine and pyrimidine metabolism

3.60

1.85

4.5

3.4

—

Viral conjunctivitis

2.22

1.85

3.2

3.7

—

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

4.31

1.84

4.6

3.9

—

Internal derangement of knee

168

1365

1.23

1.84

3.6

3.8

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

4.29

1.84

2.8

3.2

—

Benign neoplasm: Skin of eyelid, including canthus

569

1.36

1.84

3.8

3.6

—

Retinal vascular disorders

518

1.38

1.84

3.4

3.5

—

Undefined dementia

498

0.65

1.84

2.6

3.5

—

Hallux rigidus

518

1.37

1.83

3.5

3.8

—

Cramp and spasm

137

1.76

1.83

3.6

3.5

—

Acute posthaemorrhagic anaemia

115

1.84

1.83

3.9

3.7

—

Injury of muscle and tendon at wrist and hand level

459

1.40

1.83

4.0

3.4

—

Artificial opening status

214

1.60

1.82

3.8

—

Other/unspecified crystal arthropathies

3.11

1.81

2.0

4.1

—

Malignant neoplasm of small intestine, including Hilmo

101

1.90

1.81

3.1

4.2

—

Unspecified nephritic syndrome

2.07

1.81

3.7

3.8

—

Gonarthrosis,primary

486

2654

1.13

1.81

3.3

3.7

—

Other injuries of spine and trunk, level unspecified

3.09

1.81

3.0

3.7

—

Erythema nodosum

1.93

1.80

3.2

3.5

—

Tibial collateral bursitis [Pellegrini-Stieda]

3.08

1.80

2.9

4.0

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.59

1.80

4.2

4.6

—

Conduct disorder

2.59

1.80

3.4

4.5

—

Scleritis

2.79

1.80

2.8

4.5

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.79

1.80

7.5

3.5

—

Salpingitis and oophoritis

503

1.38

1.79

4.0

3.7

—

Spondylopathies (FG)

377

1.44

1.79

3.9

4.0

—

Benign neoplasm: Cerebral meninges

320

1.47

1.78

3.0

3.9

—

Other noninflammatory disorders of vagina

184

1.64

1.78

3.5

4.2

—

Retinal detachments and breaks

194

1614

1.20

1.78

3.6

—

Small fibre neuropathy

109

1.85

1.78

3.8

4.5

—

Benign neoplasm: Larynx

109

1.85

1.78

7.0

4.4

—

Other acquired deformities of musculoskeletal system and connective tissue

154

1.70

1.76

2.9

4.0

—

Atopic conjunctivitis

102

1.87

1.76

3.2

3.6

—

Other forms of systemic lupus erythematosus

3.38

1.75

3.0

3.8

—

Isolated proteinuria with specified morphological lesion

2.53

1.75

4.2

3.6

—

Certolizumab pegol

2.52

1.74

3.6

3.2

—

Disturbances of smell and taste

132

1.75

1.74

2.9

4.5

—

Benign neoplasm: Descending colon

273

1.51

1.74

2.7

3.7

—

Unspecified parasitic disease

2.71

1.73

4.3

3.4

—

Conductive hearing loss, unspecified

273

1.51

1.73

4.5

3.5

—

Unspecified lump in breast

447

1.39

1.73

3.4

3.6

—

Toxic effect of organic solvents

3.94

1.73

3.0

2.8

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

630

0.75

1.72

3.5

4.1

—

Mixed disorders of conduct and emotions

2.93

1.72

7.0

6.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

500

1.36

1.72

3.4

4.0

—

Other abnormal immunological findings in serum

2.31

1.71

5.3

3.6

—

Hyperparathyroidism

690

1.31

1.71

3.5

3.7

—

Melanocytic naevi of scalp and neck

2.07

1.71

2.9

4.0

—

Benign neoplasm: Liver/bile ducts

2.07

1.70

2.6

4.0

—

Carcinoma in situ of colon

2.02

1.70

4.1

3.7

—

Malignant neoplasm of colon

526

1.35

1.69

4.3

3.8

—

Artificial joint re-operation

275

1.50

1.69

3.0

3.9

—

Complications of other internal prosthetic devices, implants and grafts

141

1.71

1.68

3.1

3.6

—

Otitis media, unspecified

208

1.55

1.68

5.6

3.4

—

Drug-induced gout

3.24

1.67

4.3

4.9

—

Ankylosing spondylitis

243

1.53

1.67

4.1

3.9

—

DVT of lower extremities

718

1.30

1.67

3.5

—

Implicit parasitic Sepsis

3.22

1.67

4.0

4.9

—

Toxic effect of other gases, fumes and vapours

3.22

1.67

2.8

4.1

—

Arterial embolism and thrombosis of lower extremity artery

134

1.73

1.66

2.9

3.2

—

Other and unspecified disorders of pigmentation

2.85

1.66

3.6

3.1

—

Neuralgia and neuritis, unspecified

157

1.66

1.65

5.0

4.2

—

Isolated proteinuria

1.90

1.65

5.0

3.9

—

Other diseases of spinal cord

1.90

1.65

3.6

4.1

—

Colon adenocarcinoma

409

1.40

1.65

4.5

3.7

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.90

1.65

3.0

3.9

—

Vasomotor rhinitis (mode)

204

1.57

1.65

3.5

3.1

—

Other disorders of Eustachian tube

1.94

1.65

4.1

3.5

—

Other disorders of pigmentation

142

1.70

1.65

4.3

3.2

—

Fibrothorax

3.75

1.64

5.8

4.6

—

Acute and subacute iridocyclitis

633

1.31

1.64

3.0

3.6

—

Drug-induced myopathy

3.70

1.63

3.0

3.5

—

Anterior Iridocyclitis

686

1.30

1.63

3.0

3.6

—

Use of disulfiram, acamprosate or naltrexone

261

1.50

1.63

4.3

4.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.03

1.62

4.0

5.7

—

Cluster headache, strict, including avohilmo

120

1.76

1.62

3.1

3.8

—

Ectropion of eyelid

166

1.64

1.62

3.8

3.1

—

3.59

1.61

8.8

3.4

—

Primary adrenocortical insufficiency

2.53

1.60

5.1

3.7

—

Viral encephalitis, not elsewhere classified/unspecified

2.08

1.60

3.2

3.8

—

Other acute viral hepatitis

2.52

1.60

2.3

4.3

—

Malnutrition

2.02

1.60

3.1

4.2

—

Thyroiditis

198

1.57

1.59

4.5

3.5

—

IBD patients in KELA-register

697

1.29

1.59

3.5

3.9

—

Other otitis externa (chronic)

206

1.56

1.59

4.4

3.9

—

Chronic nephritic syndrome

136

1.70

1.59

3.9

4.2

—

Other specified and unspecified retinal disorders

121

1.75

1.59

4.2

3.6

—

Lesion of ulnar nerve

481

1.36

1.58

4.6

3.7

—

Excessive vomiting in pregnancy

144

1.67

1.57

2.8

4.2

—

Gout due to impairment of renal function

2.31

1.56

4.0

3.8

—

Other specified/unspecified inflammatory spondylopathies

1.85

1.56

3.4

3.6

—

Oral lichen planus

1.90

1.55

4.3

3.9

—

Ill-defined and unknown causes of mortality

373

0.61

1.55

3.2

3.5

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

322

1.43

1.55

3.3

4.0

—

Other acute skin changes due to ultraviolet radiation

107

1.79

1.55

3.7

4.3

—

Acute drug-induced interstitial lung disorder

2.47

1.55

2.8

4.2

—

Postpartum haemorrhage

417

0.67

1.55

3.5

4.2

—

Malignant neoplasm of oropharynx, including Hilmo

1.99

1.54

5.5

5.0

—

Melanoma in situ of scalp and neck

3.47

1.54

2.2

4.2

—

Combined immunodeficiencies

2.45

1.54

5.8

4.8

—

Unspecified misadventure during surgical and medical care

184

1.58

1.54

2.8

4.0

—

Malignant neoplasm of prostate

149

730

1.22

1.54

3.1

3.8

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.04

1.54

2.4

3.8

—

Behavioural disorders

2.44

1.54

3.5

4.4

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

3.43

1.54

5.0

3.5

—

Malignant neoplasm of oropharynx, including Hilmo

3.40

1.53

6.6

4.1

—

Eating disorder

122

1.72

1.53

3.1

4.3

—

Necrotizing fasciitis

3.40

1.53

6.8

2.2

—

Malignant neoplasm of nasal cavity and sinuses

3.38

1.53

4.2

2.7

—

Cluster headache, wide,, including avohilmo

130

1.70

1.53

3.1

3.7

—

Overjet

0.00

1.53

0.0

6.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.24

1.52

4.4

6.4

—

Benign neoplasm: Short bones of upper limb

0.00

1.52

0.0

3.1

—

Premenstrual syndrome

3.36

1.52

2.8

3.1

—

Disorders of magnesium metabolism

2.63

1.52

2.0

3.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

469

1.35

1.52

3.5

4.0

—

Primary open-angle glaucoma, strict

1231

0.79

1.52

3.6

—

Other and unspecified papulosquamous disorders

2.91

1.51

2.3

4.2

—

Noninflammatory disorders of female genital tract

146

598

1.23

1.51

3.5

4.0

—

Injury of blood vessels at wrist and hand level

2.90

1.51

4.8

3.3

—

Necrosis of pulp, including avohilmo

239

2054

1.16

1.50

3.8

—

Congenital malformations of the urinary system

154

1.63

1.50

3.3

4.2

—

Benign neoplasm: Duodenum

101

1.80

1.49

4.3

3.6

—

Amyloidosis

1.96

1.49

3.2

3.8

—

Disorders of synovium and tendon in diseases classified elsewhere

2.02

1.49

3.1

3.5

—

Schizophrenia or delusion

124

1008

1.23

1.49

3.4

3.9

—

Carcinoma in situ of other and unspecified digestive organs

124

1.71

1.47

4.0

3.7

—

Other symptoms and signs involving general sensations and perceptions

124

1.70

1.47

2.7

3.8

—

Other salmonella infections

109

1.75

1.47

3.1

3.4

—

Other and unspecified acute skin changes due to ultraviolet radiation

1.85

1.46

3.8

3.7

—

Hydrocephalus

305

0.59

1.46

2.7

3.7

—

Congenital malformations of the urinary system

163

1.60

1.46

3.3

4.1

—

Peroneal tendinitis

2.39

1.46

3.3

3.9

—

Dependence on enabling machines and devices, not elsewhere classified

2.39

1.46

4.1

3.7

—

Abrasion of teeth

145

1201

1.21

1.45

3.8

3.7

—

Melanoma in situ of other and unspecified parts of face

2.15

1.45

3.7

4.4

—

Intentional self-harm by unspecified means

2.52

1.45

4.6

4.1

—

Carcinoma in situ of skin of lip

3.23

1.45

3.0

3.6

—

Duodenal ulcer

437

1.35

1.45

3.8

3.6

—

Rheumatic valve diseases

1.89

1.45

3.9

3.7

—

Malignant neoplasm of oropharynx

2.14

1.45

5.8

5.6

—

Other and unspecified parapsoriasis

2.79

1.45

8.2

4.2

—

Malignant neoplasm of floor of mouth

3.18

1.44

2.8

3.9

—

Acne

171

1.58

1.44

4.6

4.9

—

severe traumatic brain injury, does not include concussion

118

958

1.23

1.44

3.1

3.5

—

Prolapse and hernia of ovary and fallopian tube

116

1.72

1.44

3.9

3.6

—

Portal vein thrombosis

2.06

1.44

2.8

4.2

—

Other disorders of nervous system

236

1.49

1.44

3.0

3.8

—

Nontoxic multinodular goitre

726

1.27

1.44

3.3

3.7

—

2.76

1.44

3.7

3.8

—

Malignant neoplasm of floor of mouth, including Hilmo

2.76

1.44

2.7

3.4

—

Crystal arthropathies, rheuma endpoint

1.99

1.44

2.9

3.8

—

Acute peritonitis

228

1.50

1.44

3.4

3.7

—

Other papulosquamous disorders

2.34

1.44

3.0

3.5

—

Acute epiglottitis

2.33

1.43

3.3

3.6

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

301

0.63

1.43

3.9

3.6

—

False labour

349

0.70

1.43

3.3

4.2

—

Malignant neoplasm of oral cavity

110

1.74

1.43

2.9

4.3

—

All dysplastic lesions of the cervix uteri, vagina or vulva

594

1.29

1.43

4.0

3.9

—

Mixed hyperlipidaemia

133

1.66

1.42

3.5

4.2

—

Other disorders of breast

311

1.42

3.5

4.1

—

Malignant neoplasm of colon, including Hilmo

691

1.28

1.42

4.1

3.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

657

1.28

1.42

4.1

4.2

—

Alzheimer’s disease, strict definition

103

1054

0.80

1.42

3.2

3.5

—

Other ill-defined and unspecified causes of mortality

339

0.62

1.41

3.1

3.4

—

Other disorders of thyroid

2.20

1.40

3.2

3.7

—

Use of levodopa decarbox-comt-inhibitor

136

0.44

1.40

2.7

3.4

—

Dermatopolymyositis (FG)

2.27

1.40

4.0

3.7

—

Open wound of thorax

2.19

1.40

2.3

4.1

—

Sequelae of injuries of head

165

1.58

1.40

4.9

4.1

—

Dystonia

173

1.57

1.40

5.7

3.5

—

Other disorders starting during childhood or adolescence

2.02

1.40

4.3

5.5

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

2.44

1.39

5.7

4.6

—

Adenomyosis (Endometriosis of uterus)

406

1.36

1.39

4.6

4.0

—

Inflammatory bowel disease, strict (require KELA)

712

1.27

1.39

3.5

3.9

—

Vitamin D deficiency

2.09

1.39

5.4

4.2

—

Benign neoplasm: Rectosigmoid junction

142

1.63

1.38

4.1

3.7

—

Injury of muscle and tendon at forearm level

2.02

1.38

4.3

3.4

—

Other inflammation of vagina/vulva

2.08

1.38

8.3

3.6

—

Contact with sharp object, undetermined intent

2.01

1.38

3.4

3.9

—

Glucosamine medication

263

1832

1.15

1.38

3.4

3.7

—

Ulcerative colitis, NAS

424

1.35

1.38

2.9

3.8

—

Secondary thrombocytopenia

2.22

1.37

3.6

3.7

—

Cardiomyopathies, Secondary/extrinsic

2.65

1.37

3.5

3.1

—

Malignant neoplasm of testis

2.21

1.37

3.4

4.0

—

Crohn's disease NAS

182

1.54

1.37

3.1

4.0

—

Erectile dysfunction, exclusion

3.01

1.37

2.4

3.4

—

Temporomandibular joint disorders, including avohilmo

152

1255

1.20

1.37

3.8

3.9

—

Other zoonotic bacterial diseases, not elsewhere classified

3.00

1.37

3.8

3.4

—

Testicular dysfunction, other/unspecified

3.00

1.37

5.4

5.1

—

Other puerperal infections

104

1.73

1.36

3.0

4.4

—

Unspecified contracted kidney

2.99

1.36

3.4

3.6

—

Degeneration of nervous system due to alcohol

1.85

1.36

3.9

5.0

—

Degeneration of the brain due to alcohol

1.85

1.36

3.9

5.0

—

Lichen planus, including avohilmo

679

1.27

1.36

3.6

3.7

—

Herpesviral keratitis and keratoconjunctivitis

135

1.64

1.36

2.9

3.6

—

LSIL lesion of the cervix uteri

207

1.50

1.34

3.9

4.1

—

LSIL lesion of the cervix uteri, vagina or vulva

298

1.41

1.34

4.0

—

Carcinoma in situ of cervix uteri

165

0.48

1.34

3.4

3.9

—

Polyarteritis nodosa and related conditions

2.15

1.34

6.1

3.4

—

Total colectomy

120

1.67

1.34

3.1

3.9

—

Total colectomy operation

120

1.67

1.34

3.1

3.9

—

Other and unspecified nerve root and plexus disorders, also in other diseases

654

1.27

1.33

3.3

3.8

—

Hypothyroidism, strict autoimmune

333

1943

1.13

1.33

3.3

3.7

—

Other disorders of iris and ciliary body

1.79

1.33

2.5

4.0

—

Postprocedural disorders of digestive system, not elsewhere classified

105

1.72

1.33

4.3

3.7

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

540

1.30

1.33

3.7

3.9

—

Cerebral aneurysm, nonruptured

274

1.43

1.32

4.6

3.9

—

Other benign neoplasms of connective and other soft tissue

316

1.40

1.32

3.7

3.8

—

Phobic anxiety disorders

257

1.44

1.32

4.0

4.5

—

Polycythaemia vera

113

1.69

1.32

2.7

3.4

—

Malignant neoplasm of prostate, including Hilmo

151

750

1.20

1.32

3.2

3.8

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

105

852

1.23

1.31

3.4

3.9

—

Malignant neoplasm of tongue, including Hilmo

1.82

1.31

2.8

4.5

—

Medical abortion

241

1134

1.15

1.31

3.7

3.9

—

Congenital malformations and deformations of the musculoskeletal system

183

1.53

1.31

2.7

4.1

—

Typhoid and paratyphoid fevers

2.54

1.31

6.7

4.3

—

Other abnormal uterine and vaginal bleeding

518

1.26

1.31

3.6

3.9

—

Benign neoplasm: Oesophagus

2.12

1.31

3.8

3.9

—

Seronegative rheumatoid arthritis

368

1.36

1.30

4.1

3.7

—

Orchitis and epididymitis

334

1.38

1.30

3.7

3.4

—

Artificial joint operation, meniscal resection

478

2813

1.10

1.30

3.3

3.8

—

Postpartum care and examination

124

0.51

1.30

3.6

4.3

—

Malignant cancer of tonsil and base of tongue, including Hilmo

1.86

1.30

3.9

4.9

—

Rosacea

343

1.37

1.29

3.9

—

Organ-limited amyloidosis

2.83

1.29

2.6

4.2

—

Implicit parasitic Sepsis

2.83

1.29

3.0

5.1

—

Toxoplasmosis

2.82

1.29

3.2

3.7

—

Other osteochondrodysplasias

2.80

1.29

3.0

3.2

—

Decubitus ulcer and pressure area

251

1.44

1.28

3.7

3.6

—

Contraceptive management

101

872

0.81

1.28

4.8

3.9

—

Mature T/NK-cell lymphomas, hilmo

2.11

1.28

2.3

3.8

—

Irregular menses

147

974

1.19

1.28

4.4

3.8

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

456

1.32

1.28

3.3

3.8

—

Iron deficiency

2.09

1.28

5.4

3.8

—

Disorders of breast

180

1398

1.17

1.27

3.3

4.0

—

Benign neoplasm: Appendix

2.07

1.27

3.6

3.9

—

Spondylopathies in diseases classified elsewhere

2.31

1.27

2.5

3.5

—

Perioral dermatitis

2.06

1.27

8.6

3.3

—

Menorrhagia

127

581

1.21

1.27

3.8

3.9

—

Malignant melanoma, including Hilmo

606

1.27

3.4

3.8

—

Unspecified mental disorder

161

1367

1.18

1.26

3.4

3.9

—

Vascular dementia (undefined)

168

1.54

1.26

3.4

3.5

—

Chronic iridocyclitis

138

1.60

1.26

3.5

3.8

—

Nummular dermatitis

294

1.40

1.26

3.1

3.3

—

Embolic stroke

186

1.51

1.26

2.9

3.7

—

Primary biliary cholangitis (PBC)

1.83

1.26

4.6

3.9

—

Pure hyperglyceridaemia

1.83

1.26

4.4

4.8

—

Open wound of hip and thigh

1.83

1.25

3.0

3.6

—

Spasmodic torticollis

1.75

1.25

4.4

3.4

—

Benign neoplasm: Endocrine pancreas

2.44

1.25

2.5

3.9

—

Schizophrenia, schizotypal and delusional disorders

123

1021

1.21

1.25

3.4

3.9

—

Acquired stenosis of external ear canal

2.25

1.25

3.5

3.4

—

Malignant neoplasm of eye and adnexa

2.43

1.25

2.0

3.6

—

Benign neoplasm of other and unspecified intrathoracic organs

2.25

1.25

2.7

4.2

—

Pustulosis palmaris et plantaris

123

1.63

1.24

3.0

3.4

—

Colorectal cancer

109

875

1.22

1.24

3.8

3.6

—

Other lesions of median nerve

100

1.71

1.24

3.2

3.5

—

Dermatopolymyositis

2.02

1.24

4.0

3.3

—

Other sexually transmitted chlamydial diseases

100

1.70

1.23

4.8

4.4

—

Open wound of shoulder and upper arm

1.92

1.23

6.2

4.0

—

Other noninflammatory disorders of vulva and perineum

220

1.46

1.23

3.6

4.0

—

Calcific tendinitis of shoulder

163

1.54

1.23

3.1

4.6

—

Carcinoma in situ of skin, other sites/unspecified

1.99

1.23

4.4

4.2

—

Monocytic leukaemia

2.70

1.23

2.6

4.0

—

Atrial septal defect

1.74

1.22

2.6

3.7

—

Other and unspecified rosacea

262

1.42

1.22

2.9

3.8

—

Typhoid and paratyphoid fevers

2.68

1.22

7.8

4.5

—

Injury of muscle and tendon at ankle and foot level

1.98

1.22

3.0

3.6

—

Cachexia

2.67

1.22

2.2

3.7

—

Certain conditions originating in the perinatal period

109

1.63

1.22

7.5

4.7

—

Contusion of toe(s) without damage to nail

2.05

1.22

5.1

3.8

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

2.66

1.22

4.4

3.8

—

Cerebral atherosclerosis

2.06

1.21

3.0

4.0

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.64

1.21

2.4

2.5

—

Other disorders of optic [2nd] nerve and visual pathways

196

1.49

1.21

5.4

4.0

—

Other dialysis

1.73

1.21

4.6

3.7

—

Malignant neoplasm of breast, ER-positive, including Hilmo

122

781

1.21

3.7

3.8

—

Bipolar affective disorders

478

1.30

1.20

2.8

4.2

—

Embolic stroke with flimmer

101

1.69

1.20

2.7

3.3

—

Foreign body in genitourinary tract

2.33

1.19

3.0

3.7

—

Atrophic disorders of skin

453

1.31

1.19

4.1

3.5

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

480

1.29

1.18

3.8

3.9

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

419

1.32

1.17

3.9

4.0

—

Post-traumatic stress disorder

125

1.60

1.17

4.0

4.4

—

Presence of other functional implants

313

1939

1.12

1.17

3.5

3.7

—

Pustular psoriasis

141

1.57

1.17

3.0

3.5

—

Postprocedural disorders of nervous system

149

1.55

1.17

2.6

3.8

—

Burns and corrosions

428

1.31

1.17

5.0

3.7

—

Alzheimer’s disease (undefined), excluding more controls

0.00

1.16

0.0

3.7

—

Alzheimer’s disease (undefined)

0.00

1.16

0.0

4.0

—

Cicatricial alopecia [scarring hair loss]

0.00

1.16

0.0

3.7

—

Other injuries of upper limb, level unspecified

2.07

1.16

3.1

4.1

—

Sexual dysfunction

2.07

1.15

2.5

3.8

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

342

1.35

1.15

4.2

—

Other retinal artery occlusion

1.74

1.15

3.3

3.8

—

Other nonscarring hair loss

2.52

1.15

10.0

3.5

—

Melanocytic naevi of other and unspecified parts of face

174

1.50

1.15

3.3

3.5

—

Exclusion endpoint for clefts

2.06

1.15

5.0

2.8

—

Benign neoplasm: Skin, unspecified

118

1.62

1.15

3.7

—

Foreign body in alimentary tract

166

1.51

1.15

3.3

4.0

—

Hypercalcemia

158

1.53

1.15

3.4

3.7

—

Varicose veins of other sites

235

0.59

1.14

4.6

4.1

—

Crystalline deposits in vitreous body

0.00

1.14

0.0

4.3

—

Brain meningioma

142

1.56

1.14

2.8

3.5

—

Procedures for purposes other than remedying health state

1.86

1.13

6.4

3.9

—

Secondary parkinsonism+Parkinsonism in other disease

111

0.45

1.13

3.0

3.4

—

Haemangioma, any site

258

1.40

1.13

2.9

3.9

—

Malignant neoplasm of corpus uteri, including Hilmo

283

0.63

1.13

4.1

3.5

—

Other surgical follow-up care

1.76

1.13

5.8

3.6

—

Infective dermatitis

387

1.32

1.13

3.9

3.6

—

Chronic myeloproliferative disease

1.92

1.13

3.3

4.1

—

Alzheimer’s disease (Late onset)

1008

0.82

1.12

3.2

3.6

—

Malignant neoplasm of other and unspecified parts of tongue

2.02

1.12

3.1

3.4

—

Dermatophytosis

475

1.29

1.12

3.1

3.6

—

Superficial injury of neck

2.01

1.12

4.0

3.6

—

Diabetic maculopathy, excluding more controls

366

0.68

1.12

3.8

3.9

—

Nontoxic single thyroid nodule

225

1.43

1.12

2.7

3.7

—

Speech and linguistic disorders

168

1.49

1.11

2.9

4.7

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.71

1.11

3.1

3.8

—

Protein-energy malnutrition of moderate and mild degree

2.28

1.11

2.7

4.7

—

Congenital malformations and deformations of the musculoskeletal system

241

1.41

1.10

3.2

4.3

—

Single spontaneous delivery

118

746

0.84

1.10

3.6

4.2

—

Disorders of psychological development

209

1.42

1.10

4.9

5.3

—

Disorders of vestibular function (Vertigo)

227

1971

1.13

1.09

4.0

3.7

—

Other disorders of peripheral nervous system

2.41

1.09

3.4

2.9

—

Crohn disease

389

1.31

1.09

3.2

4.0

—

Atlantoaxial subluxation

2.41

1.09

2.6

4.1

—

Polyarteritis nodosa

2.41

1.09

8.6

3.8

—

Myotonic disorders

2.40

1.09

4.4

2.9

—

Malignant neoplasm of corpus uteri

244

0.61

1.09

3.4

3.6

—

Ulcerative ileocolitis

104

1.64

1.09

4.2

3.9

—

Chronic suppurative otitis media, including avohilmo

260

1.39

1.09

4.3

4.1

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

1.74

1.09

3.9

3.7

—

Hypertrophy of tongue papillae

1.97

1.09

3.0

3.4

—

Injury of intra-abdominal organs

1.83

1.09

4.9

3.8

—

Colorectal neuroendocrine tumor and carcinoma

1.97

1.09

2.6

3.9

—

Other/unspecified disorders of vestibular function

152

1.52

1.09

3.3

3.6

—

Disease of hard tissues of teeth, NOS

249

1151

1.13

1.09

3.7

—

Other disorders of prostate

144

1.54

1.09

2.8

3.2

—

Other abnormal findings of blood chemistry

128

1.57

1.08

4.1

3.6

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.21

1.08

5.3

3.8

—

Disorders of optic nerve and visual pathways

269

1.38

1.08

4.9

3.9

—

Acne vulgaris

136

1.55

1.08

4.9

5.1

—

Benign neoplasm of major salivary glands

364

1.32

1.08

3.7

3.8

—

Vasculitis limited to skin, not elsewhere classified

1.70

1.08

3.5

3.4

—

Hyperkinetic disorders

181

1.46

1.08

2.4

4.9

—

Haemangioma and lymphangioma, any site

278

1.37

1.07

2.9

4.0

—

Female genital prolapse

115

542

1.20

1.07

3.5

3.9

—

Glaucoma

246

2378

0.89

1.07

3.3

3.7

—

Granulomatous disorders of skin and subcutaneous tissue

1.77

1.07

2.7

3.1

—

Carcinoma in situ of other and unspecified sites

153

1.51

1.06

4.2

3.9

—

Hydrocele

497

1.27

1.06

3.1

3.4

—

Other and unspecified spinal muscular atrophies

2.15

1.06

2.9

4.4

—

Malignant neoplasm of lip, including Hilmo

2.14

1.06

2.1

3.8

—

Brain meningioma, including Hilmo

145

1.52

1.06

2.8

3.5

—

Drug-induced neutropenia

245

1.39

1.05

3.4

3.9

—

Benign lipomatous neoplasm

132

1125

1.17

1.05

3.8

3.6

—

Urethritis and urethral syndrome

1.80

1.05

2.9

3.7

—

Periodontal disease, other/unspecified

1.80

1.05

5.3

4.1

—

Acute and transient psychotic disorders

331

1.33

1.05

3.7

4.0

—

Other specified/unspecified diseases of inner ear

2.31

1.04

2.6

4.0

—

Congenital malformations of oesophagus

2.30

1.04

4.0

4.4

—

Thyrotoxicosis with toxic multinodular goitre

212

1.42

1.04

3.3

3.6

—

Hypoglycaemia, other or unspecified

212

1.42

1.03

3.2

3.6

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

2.29

1.03

3.0

—

Lesion of sciatic nerve

178

0.56

1.03

3.5

3.9

—

Specific development disorders of scholastic skills

1.84

1.03

3.0

5.3

—

Raynaud syndrome

246

1.39

1.03

3.1

3.9

—

Other crystal arthropathies

1.75

1.03

2.9

4.8

—

Optic atrophy

1.85

1.03

2.7

3.9

—

Injury of nerves at forearm level

2.07

1.03

3.4

3.2

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

526

1.26

1.03

3.4

3.6

—

Lumbosacral root disorders, not elsewhere classified

1.93

1.02

2.7

3.5

—

Procreative management

109

762

1.19

1.02

5.6

4.3

—

Combinations of oral blood glucose lowering drugs

101

1205

0.84

1.02

3.2

3.8

—

Malignant neoplasm of thyroid gland, including Hilmo

196

1.43

1.02

4.3

4.1

—

Benign mammary dysplasia

438

1.28

1.02

3.6

—

Complications following infusion, transfusion and therapeutic injection

1.90

1.02

4.1

3.5

—

Other diseases of biliary tract

333

1.33

1.01

3.8

3.9

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

1.78

1.01

3.0

4.7

—

Deficiency of other B group vitamins

1.78

1.01

3.4

4.0

—

Benign neoplasm: Spinal cord

1.89

1.01

5.6

3.9

—

Ulcerative colitis (strict definition, require KELA)

501

1.26

1.00

3.7

3.9

—

Motorcycle rider injured in noncollision transport accidents

1.77

1.00

2.8

3.6

—

Sensorineural hearing loss

397

2462

1.10

1.00

4.2

3.6

—

Malignant neoplasm of breast, HER-positive

117

771

1.18

1.00

3.5

3.8

—

Dissection of aorta

115

1.57

1.00

3.1

3.4

—

Lesion of radial nerve

123

1.55

0.99

4.1

3.7

—

Chondrocostal junction syndrome [Tietze]

115

1.57

0.99

3.3

3.8

—

Pedestrian injured in collision with car, pick-up truck or van

1.72

0.99

4.3

3.7

—

Other and unspecified vascular occlusions

396

1.29

0.99

3.5

3.6

—

Delivery

120

746

0.85

0.99

3.6

4.2

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.85

0.99

2.1

3.9

—

Alcoholic cardiomyopathy

2.20

0.98

3.8

3.9

—

Chronic ulcer of skin, not elsewhere classified

257

1.37

0.98

3.4

3.6

—

Unspecified jaundice

156

1.48

0.98

3.0

4.0

—

Nonspecific lymphadenitis

156

1.48

0.98

3.9

—

Autoimmune hepatitis

2.19

0.98

2.0

4.6

—

Other sexually transmitted chlamydial diseases

156

1.48

0.98

4.4

5.0

—

Congenital malformations of cardiac septa

159

1.46

0.98

3.0

4.4

—

Convergence insufficiency and excess

0.00

0.98

0.0

3.6

—

Triptan medication for migraine, single purchase ok

245

1855

0.89

0.98

4.1

4.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

245

1855

0.89

0.98

4.1

4.0

—

Emotional disorders starting during childhood or adolescence

1.82

0.97

4.2

6.0

—

Early syphilis

1.96

0.97

3.4

3.9

—

Endometriosis ASRM stages 1,2

401

0.72

0.97

4.3

3.9

—

Early syphilis

1.96

0.97

3.4

3.9

—

Disorder of thyroid, unspecified

1.81

0.97

3.2

3.7

—

Other degenerative diseases of the basal ganglia

1.75

0.97

2.7

4.1

—

Parapsoriasis

1.86

0.97

6.1

4.1

—

Use of entacapone

0.00

0.97

0.0

4.4

—

Unspecified event, undetermined intent

1.75

0.96

3.8

4.3

—

Oral lichen planus, including avohilmo , including avohilmo

207

1.41

0.96

4.3

4.1

—

Foreign body entering into or through eye or natural orifice

250

1.36

0.95

4.0

—

Cerebral palsy

0.00

0.95

0.0

2.7

—

Diabetic nephropathy

641

1.22

0.95

2.8

3.5

—

Fitting and adjustment of other devices

167

1319

1.14

0.95

3.2

3.5

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

107

894

1.18

0.95

3.5

3.7

—

Chronic suppurative otitis media

216

1.39

0.95

4.2

3.7

—

Perforation of tympanic membrane

337

1.31

0.95

4.2

3.6

—

Other and unspecified vasculitis limited to skin

1.66

0.94

3.6

3.4

—

Other specified disorders of external ear

133

1.51

0.94

4.8

4.2

—

Malignant neoplasm of anus and anal canal, including Hilmo

1.91

0.94

4.0

—

Hypersomnia

1.90

0.94

2.6

4.5

—

Other meningitis

1.90

0.94

4.7

3.0

—

Polymyositis

2.25

0.94

4.3

3.7

—

Liposarcoma, including Hilmo

2.24

0.94

2.5

3.7

—

Testicular dysfunction

117

1.55

0.94

3.6

4.1

—

Whooping cough

2.24

0.93

3.2

3.9

—

Personal history of certain other diseases

2.23

0.93

1.8

3.9

—

Complications of labour and delivery

173

1096

0.88

0.93

3.7

4.0

—

Disturbance of activity and attention

163

1.44

0.93

2.3

5.1

—

Periapical abscess

191

1691

1.13

0.93

3.9

3.7

—

Residual foreign body in soft tissue

150

1.47

0.93

3.8

4.4

—

Postpartum hemorraghe, all women as controls

436

0.74

0.93

3.5

4.2

—

Major anomalies of jaw size

1.72

0.92

4.0

3.6

—

Thyroiditis, unspecified

1.74

0.92

3.8

3.6

—

Carcinoma in situ, bladder

142

1.49

0.92

3.8

4.0

—

Malignant neoplasm of tongue

1.83

0.92

3.0

3.5

—

Personal history of malignant neoplasm

209

1.39

0.92

2.9

3.6

—

Parkinson's disease, strict definition

622

0.79

0.92

3.8

3.6

—

Fibrosis of liver

2.17

0.92

2.0

4.1

—

Benign neoplasm: Nasopharynx

2.16

0.92

2.5

3.7

—

Seminoma of testis, including Hilmo

2.16

0.92

2.5

4.3

—

Inflammatory diseases of prostate (prostatitis)

508

1.24

0.92

3.2

3.5

—

Other degenerative diseases of the nervous system

129

829

1.16

0.91

3.5

3.8

—

Ingrowing nail

159

1.45

0.91

5.0

3.8

—

Nontoxic diffuse goitre

110

1.55

0.91

2.5

3.9

—

Other and unspecified injuries of shoulder and upper arm

102

1.58

0.90

4.1

3.7

—

Viral conjunctivitis

1.60

0.90

3.1

3.7

—

Lichen simplex chronicus

102

1.58

0.90

2.9

3.7

—

Pathological resorption of teeth

102

1.58

0.90

3.6

3.5

—

Postpartum hemorraghe, parous women as controls

376

0.75

0.90

3.5

3.6

—

Other infestations

1.76

0.90

3.0

3.9

—

Clear cell adenocarcinoma of kidney

151

1.46

0.90

3.3

4.0

—

Malignant neoplasm of stomach, including Hilmo

193

1.40

0.90

3.9

4.0

—

Moderate visual impairment, binocular

101

0.49

0.89

6.2

3.6

—

Cholecystectomy

344

2715

1.09

0.89

3.4

3.7

—

Colectomy operation

673

1.21

0.89

3.9

3.7

—

Atrial septal defect, secundum type

1.75

0.89

2.5

3.4

—

Car occupant injured in other and unspecified transport accidents

555

1.23

0.89

4.2

3.9

—

Radial styloid tenosynovitis [de Quervain]

135

1.49

0.89

4.1

3.5

—

Benign neoplasm: Connective and other soft tissue, unspecified

1.92

0.89

4.1

4.0

—

Other specified and unspecified disorders of eyelid

1.92

0.89

4.1

3.8

—

Alcoholic gastritis

1.92

0.89

4.2

3.6

—

Abnormalities of forces of labour

206

0.63

0.88

2.8

3.9

—

Enteropathic arthropathies

1.79

0.88

3.5

3.7

—

Hodgkin lymphoma, hilmo

1.62

0.87

3.4

4.0

—

Ankylosing spondylitis, ICD10

263

1.33

0.87

4.1

4.0

—

Car occupant injured in noncollision transport accident

1.58

0.87

5.7

3.7

—

Shock, not elsewhere classified

2.02

0.87

2.8

3.7

—

Aneurysms, operations, SAH

584

1.22

0.87

4.2

3.7

—

Dental pulpitis, including avohilmo

329

2334

0.91

0.87

3.9

4.0

—

Type 1 diabetes, strict definition, subgroup 1

119

1.51

0.87

4.7

4.0

—

Outcome of delivery

161

1.35

0.87

3.2

4.2

—

Macular hole

229

1.36

0.86

4.5

3.9

—

Maternal care for known or suspected abnormality of pelvic organs

353

0.77

0.86

2.9

4.3

—

Melanoma in situ of trunk

1.73

0.86

2.5

3.9

—

Glucagon-like peptide-1 (GLP-1) analogues

1021

0.84

0.86

3.1

3.9

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1021

0.84

0.86

3.1

3.9

—

Corns and callosities

238

1.35

0.86

3.8

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mycobacterium sp identified in Sputum by Organism specific culture

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS